Loading...

Michael Weiner, MD

Title(s)Professor, Radiology
SchoolSchool of Medicine
Address4150 Clement St
San Francisco CA 94121
Phone415-221-4810 ext. 23642
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    SUNY Upstate Medical CenterM.D.Medicine
    Mt. Sinai HospitalInternship & ResidencyMedicine
    Yale-New Haven Medical Center Clinical FellowshipMetabolism
    Yale University School of Medicine Research FellowshipNephrology
    University of Wisconsin Institute of Enzyme Research Research FellowshipBiochemistry
    Collapse Awards and Honors
    Paul Sabatier University of Toulouse, France2019Docteur Honoris Causa Degree (honorary doctorate)
    Australian Catholic University2018Honorary Professorship Award
    The American Association of Clinical Chemistry (AACC)2014Outstanding Speaker Award
    Academy of Radiology Research2014Distinguished Investigator Award
    The American Academy of Neurology and American Brain Foundation2013Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
    Alzheimer's Association Award2011Ronald and Nancy Reagan Research Institute Award
    Paul Sabatier University Toulouse, France2010Gold Medal
    Department of Veterans Affairs Medical Center2006Middleton Award for Outstanding Research
    International Society for Magnetic Resonance in Medicine2002Fellow
    Radiological Society of North America1993Editor’s Recognition Award
    American College of Cardiology1976Young Investigator Award
    American College of Physicians1973Fellow
    Veterans Administration1971Research Associate and Clinical Investigator
    National Kidney Foundation1970Fellow

    Collapse Overview 
    Collapse Overview
    Michael Weiner, MD, is a Professor in Residence in Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology at the University of California, San Francisco. He is Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative, which is the largest observational study in the world concerning Alzheimer's Disease. He is the former Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco Veterans Affairs Medical Center. After graduating from the Johns Hopkins University in 1961, he obtained his M.D, from SUNY Upstate Medical Center in Syracuse, New York in 1965, and he completed his internship and residency in Medicine from Mt. Sinai Hospital in 1967. From 1967-1968, Dr. Weiner completed a residency and clinical fellowship in Metabolism from Yale-New Haven Medical Center. In 1970, he completed a research fellowship in Nephrology from Yale University School of Medicine and a research fellowship in Biochemistry from the University of Wisconsin Institute for Enzyme Research in 1972, followed by a joint appointment in the Department of Medicine, Renal Section from the University of Wisconsin Institute in 1972. In 1974 he became an Assistant Professor of Medicine (Nephrology) at Stanford University, and in 1980 he became an Associate Professor of Medicine (Nephrology) at UCSF. In 1983, he established the Magnetic Resonance Unit at the San Francisco VA Medical Center, which became the Center for Imaging of Neurodegenerative Diseases in 2000. In 1990, he became a Professor of Radiology, Medicine, Psychiatry and Neurology at UCSF.

    Dr. Weiner’s research activities involve the development and utilization of MRI and PET for investigating and diagnosing neurodegenerative diseases. In 1980, Dr. Weiner was one of the first to perform MRS on an intact animal, and subsequently pursued his goal to develop MRI/S as a clinical tool. In 1988, his group used MRS to show that the amino acid N acetyl aspartate (NAA), a marker of healthy nerve cells, is reduced in the epileptic focus in the brain. In 2004, Dr. Weiner's group reported that reduced NAA predicts development of Alzheimer's disease in mildly impaired elderly subjects. During the past 25 years he has worked to develop and optimized the use of MRI, PET, and blood based biomarker methods to diagnose Alzheimer’s disease and other neurodegenerative disorders. Also, Dr. Weiner’s research focuses on monitoring effects of treatment to slow progressions in Alzheimer’s disease, and detecting Alzheimer’s disease early in patients who are not demented, but risk subsequent development of dementia. He is the Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative, a 14-year national longitudinal study of over 1500 subjects which is aimed at validating biomarkers for Alzheimer’s disease at 60 sites across the USA and Canada for cognitive testing, MRI, PET, and lumbar puncture. He also launched the BrainHealthRegistry.org which is an internet based registry with the overall goal of accelerating development of effective treatments for brain diseases. This website registry recruits, screens, and longitudinally monitors brain function on more than 60,000 participants. His overall research goals are to participate in the development of effective treatments and methods for early detection of Alzheimer's disease and other brain disorders. Recently he has focused on developing inexpensive, scalable, tools to identify normal elders at risk for cognitive decline and dementia, and to provide the Brain Health Registry software to facilitate the work of other investigators. Dr. Weiner has mentored over 120 postdoctoral fellows, has authored 821 peer reviewed research papers and 62 book chapters. He holds 19 separate research grants. He has received numerous honors including the Middleton Award for outstanding research in the Veterans Administration, the Nancy and Ronald Reagan Award for research from the Alzheimer’s Association, and the Potemkin Award for research in Picks Disease, Alzheimer’s disease, and other neurodegenerative disorders from the American Association of Neurology and the American Brain Foundation

    Collapse Research 
    Collapse Research Activities and Funding
    The Brain Health Registry for facilitating interdisciplinary aging research
    NIH R33AG062867Apr 15, 2020 - Feb 28, 2025
    Role: Principal Investigator
    The MobileToolbox for Monitoring Cognitive Function
    NIH U2CAG060426Sep 15, 2018 - May 31, 2023
    Role: Co-Principal Investigator
    Validation of Online Methods to Predict and Monitor Cognitive Decline
    NIH 1RF1AG059009Sep 1, 2018 - Jun 30, 2023
    Role: Principal Investigator
    Validation of Online Methods to Predict and Monitor Cognitive Decline
    NIH/NIA R01AG059009Sep 1, 2018 - May 31, 2023
    Role: Principal Investigator
    Validation of Online Methods to Predict and Monitor Cognitive Decline
    NIH RF1AG059009Sep 1, 2018 - Mar 31, 2023
    Role: Principal Investigator
    Alzheimer's Disease Neuroimaging Initiative
    NIH U01AG024904Jun 1, 2015 - Sep 29, 2010
    Role: Principal Investigator
    Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer’s Disease on Brain Tau in Vietnam Veterans using ADNI
    DoD W81XWH-14-1-0462Sep 22, 2014 - Sep 21, 2019
    Role: Principal Investigator
    Longitudinal assessment of Gulf War veterans with suspected Sarin exposure
    VA I01CX000798Oct 1, 2013 - Sep 30, 2018
    Role: Co-Principal Investigator
    Effects of traumatic brain injury and post traumatic stress disorder on Alzheimer’s disease (AD) in Veterans with mild cognitive impairment using ADNI
    DoD W81XWH-13-1-0259Sep 20, 2013 - Sep 29, 2019
    Role: Principal Investigator
    Effects of Traumatic Brain Injury (TBI) and Post Traumatic Stress Disorder (PTSD) on Alzheimer's Disease (AD) in Veterans Using Imaging and Biomarkers in the AD Neuroimaging Initiative (ADNI)
    DoD W81XWH-12-2-0012Feb 21, 2012 - Sep 29, 2019
    Role: Principal Investigator
    Amyloid Imaging, VMCI, and Analysis for ADNI
    NIH RC2AG036535Sep 30, 2009 - Aug 31, 2012
    Role: Principal Investigator
    Computational Anatomy and Multidimensional Modeling
    NIH P41RR013642Sep 7, 2009 - Sep 6, 2012
    Role: Co-Investigator
    Resource for MRI of Neurodegenerative Disorders
    NIH P41RR023953Aug 24, 2009 - Aug 23, 2011
    Role: Principal Investigator
    Resource for MRI of Neurodegenerative Disorders
    NIH P41EB015904Sep 15, 2008 - Jun 30, 2014
    Role: Principal Investigator
    Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's
    NIH R41AG030241Aug 15, 2007 - Apr 30, 2009
    Role: Co-Principal Investigator
    Frontotemporal Dementia: Genes, Images, and Emotions
    NIH P01AG019724May 1, 2005 - Aug 31, 2017
    Role: Co-Investigator
    Alzheimer's Disease Neuroimaging Initiative
    NIH U19AG024904Sep 30, 2004 - Jul 31, 2021
    Role: Principal Investigator
    New Approaches to Dementia Heterogeneity
    NIH P50AG023501Apr 1, 2004 - Aug 31, 2011
    Role: Co-Investigator
    Varian 4 Tesla MRI/MRS for Neuro-degenerative Diseases
    NIH S10RR017238Sep 30, 2002 - Mar 31, 2004
    Role: Principal Investigator
    1H MRSI OF AMYOTROPHIC LATERAL SCLEROSIS
    NIH R01NS040321Sep 11, 2000 - Jul 31, 2004
    Role: Principal Investigator
    Mental Illness Research, Education and Clinical Center
    Sierra Pacific Network MIRECC VISN 21Oct 1, 1998 - Sep 30, 2019
    Role: Principal Investigator
    CHRONIC ALCOHOL ABUSE--EFFECTS ON HIV CNS MORBIDITY
    NIH P01AA011493Sep 7, 1998 - Aug 31, 2005
    Role: Principal Investigator
    The Aging Brain: Vasculature, Ischemia, and Behavior
    NIH P01AG012435Sep 15, 1997 - Aug 31, 1999
    Role: Co-Investigator
    Prediction of cognitive decline with structural, diffusion, and perfusion MRI
    NIH R01AG010897Jul 1, 1992 - Dec 31, 2002
    Role: Principal Investigator
    1H AND 31P NMR OF HUMAN KIDNEY, HEART AND TUMORS
    NIH R01DK033293Sep 30, 1984 - Aug 31, 1992
    Role: Principal Investigator
    31P NMR SATURATION TRANSFER OF KIDNEY IN VIVO
    NIH R01AM033293Sep 30, 1984 - Aug 31, 1987
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Disease progression modelling from preclinical Alzheimer's disease (AD) to AD dementia. Sci Rep. 2021 Feb 18; 11(1):4168. PMID: 33603015.
      View in: PubMed   Mentions:    Fields:    
    2. Brain health registry GenePool study: A novel approach to online genetics research. Alzheimers Dement (N Y). 2021; 7(1):e12118. Fockler J, Kwang W, Ashford MT, Flenniken D, Hwang J, Truran D, Mackin RS, Jin C, O'Hara R, Hallmayer JF, Yesavage JA, Weiner MW, Nosheny RL. PMID: 33614891.
      View in: PubMed   Mentions:
    3. Dutch Brain Research Registry for study participant recruitment: Design and first results. Alzheimers Dement (N Y). 2021; 7(1):e12132. Zwan MD, van der Flier WM, Cleutjens S, Schouten TC, Vermunt L, Jutten RJ, van Maurik IS, Sikkes SAM, Flenniken D, Howell T, Weiner MW, Scheltens P, Prins ND. PMID: 33614897.
      View in: PubMed   Mentions:
    4. The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: A systematic review of the prediction of brain amyloid status. Alzheimers Dement. 2021 Feb 13. PMID: 33583100.
      View in: PubMed   Mentions:    Fields:    
    5. Care Coordination Strategies and Barriers during Medication Safety Incidents: a Qualitative, Cognitive Task Analysis. J Gen Intern Med. 2021 Jan 21. Russ-Jara AL, Luckhurst CL, Dismore RA, Arthur KJ, Ifeachor AP, Militello LG, Glassman PA, Zillich AJ, Weiner M. PMID: 33479924.
      View in: PubMed   Mentions:    Fields:    
    6. Modeling autosomal dominant Alzheimer's disease with machine learning. Alzheimers Dement. 2021 Jan 21. Luckett PH, McCullough A, Gordon BA, Strain J, Flores S, Dincer A, McCarthy J, Kuffner T, Stern A, Meeker KL, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, Fox NC, Jucker M, Levin J, Masters CL, Mori H, Noble JM, Salloway S, Schofield PR, Brickman AM, Brooks WS, Cash DM, Fulham MJ, Ghetti B, Jack CR, Vöglein J, Klunk W, Koeppe R, Oh H, Su Y, Weiner M, Wang Q, Swisher L, Marcus D, Koudelis D, Joseph-Mathurin N, Cash L, Hornbeck R, Xiong C, Perrin RJ, Karch CM, Hassenstab J, McDade E, Morris JC, Benzinger TLS, Bateman RJ, Ances BM. PMID: 33480178.
      View in: PubMed   Mentions:    Fields:    
    7. Clinical Thinking via Electronic Note Templates: Who Benefits? J Gen Intern Med. 2021 Jan 06. Savoy A, Frankel R, Weiner M. PMID: 33409889.
      View in: PubMed   Mentions:    Fields:    
    8. Identifying and characterizing a chronic cough cohort through electronic health records. Chest. 2020 Dec 17. Weiner M, Dexter PR, Heithoff K, Roberts AR, Liu Z, Griffith A, Hui S, Schelfhout J, Dicpinigaitis P, Doshi I, Weaver JP. PMID: 33345951.
      View in: PubMed   Mentions:    Fields:    
    9. Hoarding disorder is associated with self-reported cardiovascular / metabolic dysfunction, chronic pain, and sleep apnea. J Psychiatr Res. 2020 Dec 15; 134:15-21. Nutley SK, Camacho MR, Eichenbaum J, Nosheny RL, Weiner M, Delucchi KL, Mackin RS, Mathews CA. PMID: 33360440.
      View in: PubMed   Mentions:    Fields:    
    10. Item response theory analysis of the Clinical Dementia Rating. Alzheimers Dement. 2020 Nov 20. Li Y, Xiong C, Aschenbrenner AJ, Chang CH, Weiner MW, Nosheny RL, Mungas D, Bateman RJ, Hassenstab J, Moulder KL, Morris JC. PMID: 33215873.
      View in: PubMed   Mentions:    Fields:    
    11. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease. Neuroimage Clin. 2020; 28:102491. Dincer A, Gordon BA, Hari-Raj A, Keefe SJ, Flores S, McKay NS, Paulick AM, Shady Lewis KE, Feldman RL, Hornbeck RC, Allegri R, Ances BM, Berman SB, Brickman AM, Brooks WS, Cash DM, Chhatwal JP, Farlow MR, la Fougère C, Fox NC, Fulham MJ, Jack CR, Joseph-Mathurin N, Karch CM, Lee A, Levin J, Masters CL, McDade EM, Oh H, Perrin RJ, Raji C, Salloway SP, Schofield PR, Su Y, Villemagne VL, Wang Q, Weiner MW, Xiong C, Yakushev I, Morris JC, Bateman RJ, L S Benzinger T. PMID: 33395982.
      View in: PubMed   Mentions:    Fields:    
    12. Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative. Mol Psychiatry. 2020 Oct 26. Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Rial AM, Pascoal TA, Andreasson U, Schöll M, Weiner MW, Rosa-Neto P, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H. PMID: 33106600.
      View in: PubMed   Mentions:    Fields:    
    13. Internet-based hoarding assessment: The reliability and predictive validity of the internet-based Hoarding Rating Scale, Self-Report. Psychiatry Res. 2020 12; 294:113505. Nutley SK, Bertolace L, Vieira LS, Nguyen B, Ordway A, Simpson H, Zakrzewski J, Camacho MR, Eichenbaum J, Nosheny R, Weiner M, Mackin RS, Mathews CA. PMID: 33070108.
      View in: PubMed   Mentions:    Fields:    
    14. Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease. Neurol Genet. 2020 Dec; 6(6):e517. Park YH, Hodges A, Simmons A, Lovestone S, Weiner MW, Kim S, Saykin AJ, Nho K. PMID: 33134515.
      View in: PubMed   Mentions:
    15. Predicting amyloid status using self-report information from an online research and recruitment registry: The Brain Health Registry. Alzheimers Dement (Amst). 2020; 12(1):e12102. Ashford MT, Neuhaus J, Jin C, Camacho MR, Fockler J, Truran D, Mackin RS, Rabinovici GD, Weiner MW, Nosheny RL. PMID: 33005723.
      View in: PubMed   Mentions:
    16. Association between APOE e2 and Aß burden in patients with Alzheimer- and vascular-type cognitive impairment. Neurology. 2020 10 27; 95(17):e2354-e2365. Lee JS, Lee H, Park S, Choe Y, Park YH, Cheon BK, Hahn A, Ossenkoppele R, Kim HJ, Kim S, Yoo H, Jang H, Cho SH, Kim SJ, Kim JP, Jung YH, Park KC, DeCarli C, Weiner MW, Na DL, Seo SW. PMID: 32928967.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    17. Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology. Alzheimers Dement. 2020 09; 16(9):1213-1223. PMID: 32755048.
      View in: PubMed   Mentions:    Fields:    
    18. Validation of online functional measures in cognitively impaired older adults. Alzheimers Dement. 2020 10; 16(10):1426-1437. Nosheny RL, Camacho MR, Jin C, Neuhaus J, Truran D, Flenniken D, Ashford M, Carrillo MC, Fargo KN, Hendrix J, Hanna L, Rabinovici G, Maruff P, Mackin RS, Weiner MW. PMID: 32715602.
      View in: PubMed   Mentions: 1     Fields:    
    19. Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer's Disease Neuroimaging Initiative Depression Project. Biol Psychiatry. 2020 Jul 02. PMID: 32980132.
      View in: PubMed   Mentions:    Fields:    
    20. Late contributions of repetitive head impacts and TBI to depression symptoms and cognition. Neurology. 2020 08 18; 95(7):e793-e804. Alosco ML, Tripodis Y, Baucom ZH, Mez J, Stein TD, Martin B, Haller O, Conneely S, McClean M, Nosheny R, Mackin S, McKee AC, Weiner MW, Stern RA. PMID: 32591472.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiol Dis. 2020 08; 142:104960. Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J, Flores S, Keefe S, Dincer A, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal J, Cruchaga C, Ewers M, Fox NN, Ghetti B, Goate A, Graff-Radford NR, Hassenstab JJ, Hornbeck R, Jack C, Johnson K, Joseph-Mathurin N, Karch CM, Koeppe RA, Lee AKW, Levin J, Masters C, McDade E, Perrin RJ, Rowe CC, Salloway S, Saykin AJ, Sperling R, Su Y, Villemagne VL, Vöglein J, Weiner M, Xiong C, Fagan AM, Morris JC, Bateman RJ, Benzinger TLS, Jucker M, Gordon BA. PMID: 32522711.
      View in: PubMed   Mentions: 1     Fields:    
    22. A Time Motion Study Evaluating the Impact of Geographic Cohorting of Hospitalists. J Hosp Med. 2020 06; 15(6):338-344. Kara A, Flanagan ME, Gruber R, Lane KA, Bo N, Kroenke K, Weiner M. PMID: 31891555.
      View in: PubMed   Mentions: 1     Fields:    
    23. Effects of sex, race, ethnicity, and education on online aging research participation. Alzheimers Dement (N Y). 2020; 6(1):e12028. Ashford MT, Eichenbaum J, Williams T, Camacho MR, Fockler J, Ulbricht A, Flenniken D, Truran D, Mackin RS, Weiner MW, Nosheny RL. PMID: 32478165.
      View in: PubMed   Mentions:
    24. Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers. Neurology. 2020 05 19; 94(20):e2088-e2098. Bernath MM, Bhattacharyya S, Nho K, Barupal DK, Fiehn O, Baillie R, Risacher SL, Arnold M, Jacobson T, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, Kaddurah-Daouk R, Saykin AJ. PMID: 32358220.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report. J Prev Alzheimers Dis. 2020 Apr 06; 1-6. Gauthier S, Aisen PS, Cummings J, Detke MJ, Longo FM, Raman R, Sabbagh M, Schneider L, Tanzi R, Tariot P, Weiner M, Touchon J, Vellas B. PMID: 32420298.
      View in: PubMed   Mentions: 2     Fields:    
    26. Sex and APOE e4 genotype modify the Alzheimer's disease serum metabolome. Nat Commun. 2020 03 02; 11(1):1148. Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, MahmoudianDehkordi S, Louie G, Moseley MA, Thompson JW, John-Williams LS, Tenenbaum JD, Blach C, Chang R, Brinton RD, Baillie R, Han X, Trojanowski JQ, Shaw LM, Martins R, Weiner MW, Trushina E, Toledo JB, Meikle PJ, Bennett DA, Krumsiek J, Doraiswamy PM, Saykin AJ, Kaddurah-Daouk R, Kastenmüller G. PMID: 32123170.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    27. A randomized study on the usefulness of an electronic outpatient hypoglycemia risk calculator for clinicians of patients with diabetes in a safety-net institution. Curr Med Res Opin. 2020 04; 36(4):583-593. Weiner M, Cummins J, Raji A, Ofner S, Iglay K, Teal E, Li X, Engel SS, Knapp K, Rajpathak S, Baker J, Chatterjee AK, Radican L. PMID: 31951747.
      View in: PubMed   Mentions:    Fields:    
    28. Data-Driven Participant Recruitment: Findings from the Alzheimer's Disease Neuroimaging Initiative 3. J Prev Alzheimers Dis. 2020; 7(2):122-127. Barger C, Fockler J, Kwang W, Moore S, Flenniken D, Ulbricht A, Aisen P, Weiner MW. PMID: 32236401.
      View in: PubMed   Mentions:    Fields:    
    29. Cortical ß-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation. J Prev Alzheimers Dis. 2020; 7(2):128-134. Hooper C, Coley N, De Souto Barreto P, Payoux P, Salabert AS, Andrieu S, Weiner M, Vellas B. PMID: 32236402.
      View in: PubMed   Mentions:    Fields:    
    30. Dysregulated Fc gamma receptor-mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis. Neurobiol Aging. 2020 04; 88:24-32. Park YH, Hodges A, Risacher SL, Lin K, Jang JW, Ahn S, Kim S, Lovestone S, Simmons A, Weiner MW, Saykin AJ, Nho K. PMID: 31901293.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    31. Study partner-reported decline identifies cognitive decline and dementia risk. Ann Clin Transl Neurol. 2019 12; 6(12):2448-2459. Nosheny RL, Jin C, Neuhaus J, Insel PS, Mackin RS, Weiner MW. PMID: 31721455.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Too Many Don'ts and Not Enough Do's? A Survey of Hospitals About Their Portal Instructions for Patients. J Gen Intern Med. 2020 Apr; 35(4):1029-1034. Lee JL, Williams CE, Baird S, Matthias MS, Weiner M. PMID: 31720967.
      View in: PubMed   Mentions:    Fields:    
    33. Forced Inefficiencies of the Electronic Health Record. J Gen Intern Med. 2019 11; 34(11):2299-2301. Weiner M. PMID: 31452040.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    34. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat Genet. 2019 11; 51(11):1624-1636. Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, Teumer A, van der Lee SJ, Yang J, Yanek LR, Lee TV, Li S, Hu Y, Koh JY, Eicher JD, Desrivières S, Arias-Vasquez A, Chauhan G, Athanasiu L, Rentería ME, Kim S, Hoehn D, Armstrong NJ, Chen Q, Holmes AJ, den Braber A, Kloszewska I, Andersson M, Espeseth T, Grimm O, Abramovic L, Alhusaini S, Milaneschi Y, Papmeyer M, Axelsson T, Ehrlich S, Roiz-Santiañez R, Kraemer B, Håberg AK, Jones HJ, Pike GB, Stein DJ, Stevens A, Bralten J, Vernooij MW, Harris TB, Filippi I, Witte AV, Guadalupe T, Wittfeld K, Mosley TH, Becker JT, Doan NT, Hagenaars SP, Saba Y, Cuellar-Partida G, Amin N, Hilal S, Nho K, Mirza-Schreiber N, Arfanakis K, Becker DM, Ames D, Goldman AL, Lee PH, Boomsma DI, Lovestone S, Giddaluru S, Le Hellard S, Mattheisen M, Bohlken MM, Kasperaviciute D, Schmaal L, Lawrie SM, Agartz I, Walton E, Tordesillas-Gutierrez D, Davies GE, Shin J, Ipser JC, Vinke LN, Hoogman M, Jia T, Burkhardt R, Klein M, Crivello F, Janowitz D, Carmichael O, Haukvik UK, Aribisala BS, Schmidt H, Strike LT, Cheng CY, Risacher SL, Pütz B, Fleischman DA, Assareh AA, Mattay VS, Buckner RL, Mecocci P, Dale AM, Cichon S, Boks MP, Matarin M, Penninx BWJH, Calhoun VD, Chakravarty MM, Marquand AF, Macare C, Kharabian Masouleh S, Oosterlaan J, Amouyel P, Hegenscheid K, Rotter JI, Schork AJ, Liewald DCM, de Zubicaray GI, Wong TY, Shen L, Sämann PG, Brodaty H, Roffman JL, de Geus EJC, Tsolaki M, Erk S, van Eijk KR, Cavalleri GL, van der Wee NJA, McIntosh AM, Gollub RL, Bulayeva KB, Bernard M, Richards JS, Himali JJ, Loeffler M, Rommelse N, Hoffmann W, Westlye LT, Valdés Hernández MC, Hansell NK, van Erp TGM, Wolf C, Kwok JBJ, Vellas B, Heinz A, Olde Loohuis LM, Delanty N, Ho BC, Ching CRK, Shumskaya E, Singh B, Hofman A, van der Meer D, Homuth G, Psaty BM, Bastin ME, Montgomery GW, Foroud TM, Reppermund S, Hottenga JJ, Simmons A, Meyer-Lindenberg A, Cahn W, Whelan CD, van Donkelaar MMJ, Yang Q, Hosten N, Green RC, Thalamuthu A, Mohnke S, Hulshoff Pol HE, Lin H, Jack CR, Schofield PR, Mühleisen TW, Maillard P, Potkin SG, Wen W, Fletcher E, Toga AW, Gruber O, Huentelman M, Davey Smith G, Launer LJ, Nyberg L, Jönsson EG, Crespo-Facorro B, Koen N, Greve DN, Uitterlinden AG, Weinberger DR, Steen VM, Fedko IO, Groenewold NA, Niessen WJ, Toro R, Tzourio C, Longstreth WT, Ikram MK, Smoller JW, van Tol MJ, Sussmann JE, Paus T, Lemaître H, Schroeter ML, Mazoyer B, Andreassen OA, Holsboer F, Depondt C, Veltman DJ, Turner JA, Pausova Z, Schumann G, van Rooij D, Djurovic S, Deary IJ, McMahon KL, Müller-Myhsok B, Brouwer RM, Soininen H, Pandolfo M, Wassink TH, Cheung JW, Wolfers T, Martinot JL, Zwiers MP, Nauck M, Melle I, Martin NG, Kanai R, Westman E, Kahn RS, Sisodiya SM, White T, Saremi A, van Bokhoven H, Brunner HG, Völzke H, Wright MJ, van 't Ent D, Nöthen MM, Ophoff RA, Buitelaar JK, Fernández G, Sachdev PS, Rietschel M, van Haren NEM, Fisher SE, Beiser AS, Francks C, Saykin AJ, Mather KA, Romanczuk-Seiferth N, Hartman CA, DeStefano AL, Heslenfeld DJ, Weiner MW, Walter H, Hoekstra PJ, Nyquist PA, Franke B, Bennett DA, Grabe HJ, Johnson AD, Chen C, van Duijn CM, Lopez OL, Fornage M, Wardlaw JM, Schmidt R, DeCarli C, De Jager PL, Villringer A, Debette S, Gudnason V, Medland SE, Shulman JM, Thompson PM, Seshadri S, Ikram MA. PMID: 31636452.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    35. TADPOLE Challenge: Accurate Alzheimer's disease prediction through crowdsourced forecasting of future data. Predict Intell Med. 2019 10; 11843:1-10. Marinescu RV, Oxtoby NP, Young AL, Bron EE, Toga AW, Weiner MW, Barkhof F, Fox NC, Golland P, Klein S, Alexander DC. PMID: 32587957.
      View in: PubMed   Mentions:
    36. Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status. Alzheimers Dement. 2019 11; 15(11):1392-1401. Delrieu J, Payoux P, Carrié I, Cantet C, Weiner M, Vellas B, Andrieu S. PMID: 31558366.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. Adapting Cognitive Task Analysis to Investigate Clinical Decision Making and Medication Safety Incidents. J Patient Saf. 2019 09; 15(3):191-197. PMID: 28471774.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients. Eur J Nucl Med Mol Imaging. 2020 02; 47(2):292-303. Jang H, Kim HJ, Park S, Park YH, Choe Y, Cho H, Lyoo CH, Yoon U, Lee JS, Kim Y, Kim SJ, Kim JP, Jung YH, Ryu YH, Choi JY, Moon SH, Seong JK, DeCarli C, Weiner MW, Lockhart SN, Cho SH, Na DL, Seo SW. PMID: 31471715.
      View in: PubMed   Mentions:    Fields:    
    39. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Sci Transl Med. 2019 08 28; 11(507). Ewers M, Franzmeier N, Suárez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M, Trojanowski JQ, Shaw LM, Weiner MW, Haass C. PMID: 31462511.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    40. Predictive modeling of hypoglycemia for clinical decision support in evaluating outpatients with diabetes mellitus. Curr Med Res Opin. 2019 11; 35(11):1885-1891. Li X, Yu S, Zhang Z, Radican L, Cummins J, Engel SS, Iglay K, Duke J, Baker J, Brodovicz KG, Naik RG, Leventhal J, Chatterjee AK, Rajpathak S, Weiner M. PMID: 31234649.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Erratum to "Cognitive requirements for primary care providers during the referral process: Information needed from and interactions with an electronic health record system" [Int. J. Med. Inform. 129 (2019) 88-94]. Int J Med Inform. 2019 Sep; 129:394. Savoy A, Militello L, Diiulio J, Midboe AM, Weiner M, Abbaszadegan H, Herout J. PMID: 31477213.
      View in: PubMed   Mentions:    Fields:    
    42. Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults. Neurobiol Aging. 2019 10; 82:110-119. Nosheny RL, Insel PS, Mattsson N, Tosun D, Buckley S, Truran D, Schuff N, Aisen PS, Weiner MW. PMID: 31437719.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. 2019 07 23; 93(4):e322-e333. Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, Palmqvist S, Masters CL, Maruff PT, Hansson O, Mattsson N. PMID: 31289148.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    44. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. JAMA Netw Open. 2019 07 03; 2(7):e197978. Nho K, Kueider-Paisley A, Ahmad S, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn C, Saykin AJ, Kaddurah-Daouk R. PMID: 31365104.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Letter to the Author, concerning the publication: Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury. Mohamed AZ, et al. Neuroimaging Clinical 2018 Jun 5;19:716-726. Neuroimage Clin. 2019; 23:101868. Landau S, Harvey D, Weiner MW. PMID: 31347502.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Latent Classes of Cognitive Functioning Among Depressed Older Adults Without Dementia. J Int Neuropsychol Soc. 2019 09; 25(8):811-820. Morin RT, Insel P, Nelson C, Butters M, Bickford D, Landau S, Saykin A, Weiner M, Mackin RS. PMID: 31232250.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Cognitive requirements for primary care providers during the referral process: Information needed from and interactions with an electronic health record system. Int J Med Inform. 2019 09; 129:88-94. Savoy A, Militello L, Diiulio J, Midboe AM, Weiner M, Abbaszadegan H, Herout J. PMID: 31445294.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: a qualitative, cognitive task analysis. BMJ Open. 2019 05 24; 9(5):e027439. Elkhadragy N, Ifeachor AP, Diiulio JB, Arthur KJ, Weiner M, Militello LG, Glassman PA, Zillich AJ, Russ AL. PMID: 31129589.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Recommendations for the Evaluation of Cross-System Care Coordination from the VA State-of-the-art Working Group on VA/Non-VA Care. J Gen Intern Med. 2019 05; 34(Suppl 1):18-23. Mattocks KM, Cunningham K, Elwy AR, Finley EP, Greenstone C, Mengeling MA, Pizer SD, Vanneman ME, Weiner M, Bastian LA. PMID: 31098968.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia. Alzheimers Dement. 2019 05; 15(5):686-698. Sugarman MA, McKee AC, Stein TD, Tripodis Y, Besser LM, Martin B, Palmisano JN, Steinberg EG, O'Connor MK, Au R, McClean M, Killiany R, Mez J, Weiner MW, Kowall NW, Stern RA, Alosco ML. PMID: 30852157.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3. Front Neuroinform. 2019; 13:2. Zavaliangos-Petropulu A, Nir TM, Thomopoulos SI, Reid RI, Bernstein MA, Borowski B, Jack CR, Weiner MW, Jahanshad N, Thompson PM. PMID: 30837858.
      View in: PubMed   Mentions:
    52. Outcomes of an RCT of videoconference vs. in-person or in-clinic nutrition and exercise in midlife adults with obesity. Obes Sci Pract. 2019 Apr; 5(2):111-119. Clark DO, Keith N, Weiner M, Xu H. PMID: 31019728.
      View in: PubMed   Mentions:
    53. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration. Brain. 2019 02 01; 142(2):460-470. Tan CH, Bonham LW, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL, Yaffe K, Schellenberg GD, Kauppi K, Holland D, McEvoy LK, Kukull WA, Tosun D, Weiner MW, Sperling RA, Bennett DA, Hyman BT, Andreassen OA, Dale AM, Desikan RS. PMID: 30689776.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-ß pathology. Mol Neurodegener. 2019 01 10; 14(1):1. Suárez-Calvet M, Morenas-Rodríguez E, Kleinberger G, Schlepckow K, Araque Caballero MÁ, Franzmeier N, Capell A, Fellerer K, Nuscher B, Eren E, Levin J, Deming Y, Piccio L, Karch CM, Cruchaga C, Shaw LM, Trojanowski JQ, Weiner M, Ewers M, Haass C. PMID: 30630532.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    55. Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report. J Prev Alzheimers Dis. 2019; 6(3):169-173. Bateman RJ, Blennow K, Doody R, Hendrix S, Lovestone S, Salloway S, Schindler R, Weiner M, Zetterberg H, Aisen P, Vellas B. PMID: 31062827.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    56. APOE Effect on Amyloid-ß PET Spatial Distribution, Deposition Rate, and Cut-Points. J Alzheimers Dis. 2019; 69(3):783-793. Toledo JB, Habes M, Sotiras A, Bjerke M, Fan Y, Weiner MW, Shaw LM, Davatzikos C, Trojanowski JQ. PMID: 31127775.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Cognitive Performance in Parkinson's Disease in the Brain Health Registry. J Alzheimers Dis. 2019; 68(3):1029-1038. Cholerton B, Weiner MW, Nosheny RL, Poston KL, Mackin RS, Tian L, Ashford JW, Montine TJ. PMID: 30909225.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort. J Alzheimers Dis. 2019; 71(1):33-43. Nudelman KNH, Lin J, Lane KA, Nho K, Kim S, Faber KM, Risacher SL, Foroud TM, Gao S, Davis JW, Weiner MW, Saykin AJ. PMID: 31322561.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    59. Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical ß-amyloid Deposition. J Prev Alzheimers Dis. 2019; 6(4):274-282. Tolbert S, Liu Y, Hellegers C, Petrella JR, Weiner MW, Wong TZ, Murali Doraiswamy P. PMID: 31686100.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    60. Lessons and Outcomes of Mobile Acute Care for Elders Consultation in a Veterans Affairs Medical Center. J Am Geriatr Soc. 2019 04; 67(4):818-824. Schubert CC, Parks R, Coffing JM, Daggy J, Slaven JE, Weiner M. PMID: 30575012.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med. 2018 12; 10(12). Suárez-Calvet M, Capell A, Araque Caballero MÁ, Morenas-Rodríguez E, Fellerer K, Franzmeier N, Kleinberger G, Eren E, Deming Y, Piccio L, Karch CM, Cruchaga C, Paumier K, Bateman RJ, Fagan AM, Morris JC, Levin J, Danek A, Jucker M, Masters CL, Rossor MN, Ringman JM, Shaw LM, Trojanowski JQ, Weiner M, Ewers M, Haass C. PMID: 30482868.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    62. Military-related risk factors for dementia. Alzheimers Dement. 2018 12; 14(12):1651-1662. Snyder HM, Carare RO, DeKosky ST, de Leon MJ, Dykxhoorn D, Gan L, Gardner R, Hinds SR, Jaffee M, Lamb BT, Landau S, Manley G, McKee A, Perl D, Schneider JA, Weiner M, Wellington C, Yaffe K, Bain L, Pacifico AM, Carrillo MC. PMID: 30415806.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    63. Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes. BMC Cancer. 2018 Oct 24; 18(1):1035. Steffensen EH, Cary C, Jensen JB, Larsson H, Weiner M, Nørgaard M. PMID: 30355276.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement. 2019 01; 15(1):76-92. MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW, St John Williams L, Tenenbaum JD, Blach C, Baillie R, Han X, Bhattacharyya S, Toledo JB, Schafferer S, Klein S, Koal T, Risacher SL, Kling MA, Motsinger-Reif A, Rotroff DM, Jack J, Hankemeier T, Bennett DA, De Jager PL, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn CM, Saykin AJ, Kastenmüller G, Kaddurah-Daouk R. PMID: 30337151.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    65. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement. 2019 02; 15(2):232-244. Nho K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Jia W, Xie G, Ahmad S, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, Saykin AJ, Kaddurah-Daouk R. PMID: 30337152.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    66. Online study partner-reported cognitive decline in the Brain Health Registry. Alzheimers Dement (N Y). 2018; 4:565-574. Nosheny RL, Camacho MR, Insel PS, Flenniken D, Fockler J, Truran D, Finley S, Ulbricht A, Maruff P, Yaffe K, Mackin RS, Weiner MW. PMID: 30386821.
      View in: PubMed   Mentions:
    67. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2019 01; 15(1):106-152. Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ. PMID: 30321505.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    68. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease. Brain. 2018 10 01; 141(10):3065-3080. Araque Caballero MÁ, Suárez-Calvet M, Duering M, Franzmeier N, Benzinger T, Fagan AM, Bateman RJ, Jack CR, Levin J, Dichgans M, Jucker M, Karch C, Masters CL, Morris JC, Weiner M, Rossor M, Fox NC, Lee JH, Salloway S, Danek A, Goate A, Yakushev I, Hassenstab J, Schofield PR, Haass C, Ewers M. PMID: 30239611.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    69. Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults. J Clin Sleep Med. 2018 09 15; 14(9):1587-1594. Mohlenhoff BS, Insel PS, Mackin RS, Neylan TC, Flenniken D, Nosheny R, Richards A, Maruff P, Weiner MW. PMID: 30176964.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging. JAMA Neurol. 2018 08 01; 75(8):999-1007. Kim HJ, Park S, Cho H, Jang YK, San Lee J, Jang H, Kim Y, Kim KW, Ryu YH, Choi JY, Moon SH, Weiner MW, Jagust WJ, Rabinovici GD, DeCarli C, Lyoo CH, Na DL, Seo SW. PMID: 29799981.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    71. A cognitive systems engineering design approach to improve the usability of electronic order forms for medical consultation. J Biomed Inform. 2018 09; 85:138-148. Savoy A, Militello LG, Patel H, Flanagan ME, Russ AL, Daggy JK, Weiner M, Saleem JJ. PMID: 30071316.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment. Int J Geriatr Psychiatry. 2018 10; 33(10):1305-1311. Gonzales MM, Insel PS, Nelson C, Tosun D, Schöll M, Mattsson N, Sacuiu S, Bickford D, Weiner MW, Mackin RS. PMID: 29953668.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry. Alzheimers Dement (Amst). 2018; 10:573-582. Mackin RS, Insel PS, Truran D, Finley S, Flenniken D, Nosheny R, Ulbright A, Comacho M, Bickford D, Harel B, Maruff P, Weiner MW. PMID: 30406176.
      View in: PubMed   Mentions:
    74. Comparative usability evaluation of consultation order templates in a simulated primary care environment. Appl Ergon. 2018 Nov; 73:22-32. Savoy A, Patel H, Flanagan ME, Daggy JK, Russ AL, Weiner M. PMID: 30098639.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Response to Zywieck and Kirkby paper. Neurobiol Aging. 2018 09; 69:298-299. Weiner MW, Toga A, Harvey D, Donohue M, Beckett L. PMID: 29929929.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    76. The Brain Health Registry: An internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 2018 08; 14(8):1063-1076. Weiner MW, Nosheny R, Camacho M, Truran-Sacrey D, Mackin RS, Flenniken D, Ulbricht A, Insel P, Finley S, Fockler J, Veitch D. PMID: 29754989.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    77. Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials. Alzheimers Dement. 2018 08; 14(8):1077-1087. Iwatsubo T, Iwata A, Suzuki K, Ihara R, Arai H, Ishii K, Senda M, Ito K, Ikeuchi T, Kuwano R, Matsuda H, Sun CK, Beckett LA, Petersen RC, Weiner MW, Aisen PS, Donohue MC. PMID: 29753531.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    78. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. PLoS One. 2018; 13(5):e0195838. Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, F?rster S, Schofield PR, Sperling RA, Johnson KA, Chhatwal JP, Salloway S, Correia S, Jack CR, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AM. PMID: 29742105.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    79. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain. 2018 04 01; 141(4):1186-1200. Franzmeier N, Düzel E, Jessen F, Buerger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Teipel S, Kilimann I, Ramirez A, Rossor M, Jucker M, Chhatwal J, Spottke A, Boecker H, Brosseron F, Falkai P, Fliessbach K, Heneka MT, Laske C, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Kofler B, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Weiner M, Lee JH, Salloway S, Danek A, Goate A, Schofield PR, Bateman RJ, Ewers M. PMID: 29462334.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    80. A critical appraisal of guidelines for electronic communication between patients and clinicians: the need to modernize current recommendations. J Am Med Inform Assoc. 2018 04 01; 25(4):413-418. Lee JL, Matthias MS, Menachemi N, Frankel RM, Weiner M. PMID: 29025086.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    81. A National County-Level Assessment of U.S. Nursing Facility Characteristics Associated with Long-Term Exposure to Traffic Pollution in Older Adults. Int J Environ Res Public Health. 2018 03 10; 15(3). PMID: 29534437.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    82. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol. 2018 03; 17(3):241-250. PMID: 29397305.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    83. Preserved Structural Network Organization Mediates Pathology Spread in Alzheimer's Disease Spectrum Despite Loss of White Matter Tract Integrity. J Alzheimers Dis. 2018; 65(3):747-764. Powell F, Tosun D, Sadeghi R, Weiner M, Raj A. PMID: 29578480.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    84. What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force. J Prev Alzheimers Dis. 2018; 5(3):171-174. Aisen PS, Siemers E, Michelson D, Salloway S, Sampaio C, Carrillo MC, Sperling R, Doody R, Scheltens P, Bateman R, Weiner M, Vellas B. PMID: 29972209.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    85. The Relationship of Omega 3 Polyunsaturated Fatty Acids in Red Blood Cell Membranes with Cognitive Function and Brain Structure: A Review Focussed on Alzheimer's Disease. J Prev Alzheimers Dis. 2018; 5(1):78-84. Hooper C, De Souto Barreto P, Pahor M, Weiner M, Vellas B. PMID: 29405237.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    86. What We Learn from the CTAD (Clinical Trials Alzheimer's Disease) 2018. J Prev Alzheimers Dis. 2018; 5(4):214-215. Vellas B, Aisen P, Weiner M, Touchon J. PMID: 30298178.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    87. Amyloid pathology in the progression to mild cognitive impairment. Neurobiol Aging. 2018 04; 64:76-84. Insel PS, Hansson O, Mackin RS, Weiner M, Mattsson N. PMID: 29353101.
      View in: PubMed   Mentions: 5     Fields:    
    88. Systematic comparison of different techniques to measure hippocampal subfield volumes in ADNI2. Neuroimage Clin. 2018; 17:1006-1018. PMID: 29527502.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    89. Amyloid Associated Intermittent Network Disruptions in Cognitively Intact Older Subjects: Structural Connectivity Matters. Front Aging Neurosci. 2017; 9:418. Mueller SG, Weiner MW. PMID: 29311904.
      View in: PubMed   Mentions:
    90. Implementing Models of Geriatric Care-Behind the Scenes. J Am Geriatr Soc. 2018 02; 66(2):364-366. Chodosh J, Weiner M. PMID: 29130479.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial. EBioMedicine. 2017 Nov; 25:112-121. Sigal GB, Segal MR, Mathew A, Jarlsberg L, Wang M, Barbero S, Small N, Haynesworth K, Davis JL, Weiner M, Whitworth WC, Jacobs J, Schorey J, Lewinsohn DM, Nahid P. PMID: 29100778.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    92. Dementia Risk in Posttraumatic Stress Disorder: the Relevance of Sleep-Related Abnormalities in Brain Structure, Amyloid, and Inflammation. Curr Psychiatry Rep. 2017 Oct 16; 19(11):89. Mohlenhoff BS, O'Donovan A, Weiner MW, Neylan TC. PMID: 29035423.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. Traumatic brain injury may not increase the risk of Alzheimer disease. Neurology. 2017 Oct 31; 89(18):1923-1925. Weiner MW, Crane PK, Montine TJ, Bennett DA, Veitch DP. PMID: 28978654.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    94. Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2017 Dec; 60:92-103. PMID: 28941407.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    95. Systematic Heuristic Evaluation of Computerized Consultation Order Templates: Clinicians' and Human Factors Engineers' Perspectives. J Med Syst. 2017 Aug; 41(8):129. PMID: 28735373.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    96. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement. 2018 01; 14(1):43-53. PMID: 28738187.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    97. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons. JAMA. 2017 06 13; 317(22):2305-2316. PMID: 28609533.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    98. Triglycerides are negatively correlated with cognitive function in nondemented aging adults. Neuropsychology. 2017 Sep; 31(6):682-688. PMID: 28604016.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    99. Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary Report. Alzheimers Dement (N Y). 2017 06; 3(2):177-188. PMID: 28758146.
      View in: PubMed   Mentions:
    100. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease. BMC Med Genomics. 2017 05 24; 10(Suppl 1):29. PMID: 28589856.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    101. Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease. Front Neurosci. 2017; 11:281. Insel PS, Ossenkoppele R, Gessert D, Jagust W, Landau S, Hansson O, Weiner MW, Mattsson N. PMID: 28567001.
      View in: PubMed   Mentions:
    102. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimers Dement. 2017 Nov; 13(11):1197-1206. PMID: 28501451.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    103. Association between tau deposition and antecedent amyloid-ß accumulation rates in normal and early symptomatic individuals. Brain. 2017 May 01; 140(5):1499-1512. Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW. PMID: 28334939.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    104. Long-term Health-related Quality of Life Outcomes Following Radical Cystectomy. Urology. 2017 Aug; 106:82-86. PMID: 28456541.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. ?Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression. Am J Geriatr Psychiatry. 2017 Sep; 25(9):980-991. Gonzales MM, Insel PS, Nelson C, Tosun D, Mattsson N, Mueller SG, Sacuiu S, Bickford D, Weiner MW, Mackin RS. PMID: 28629965.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    106. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017 May; 16(5):377-389. PMID: 28359749.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    107. Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration. Brain Behav. 2017 04; 7(4):e00675. PMID: 28413716.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Metabolic network failures in Alzheimer's disease: A biochemical road map. Alzheimers Dement. 2017 Sep; 13(9):965-984. Toledo JB, Arnold M, Kastenmüller G, Chang R, Baillie RA, Han X, Thambisetty M, Tenenbaum JD, Suhre K, Thompson JW, John-Williams LS, MahmoudianDehkordi S, Rotroff DM, Jack JR, Motsinger-Reif A, Risacher SL, Blach C, Lucas JE, Massaro T, Louie G, Zhu H, Dallmann G, Klavins K, Koal T, Kim S, Nho K, Shen L, Casanova R, Varma S, Legido-Quigley C, Moseley MA, Zhu K, Henrion MYR, van der Lee SJ, Harms AC, Demirkan A, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Saykin AJ, Weiner MW, Doraiswamy PM, Kaddurah-Daouk R. PMID: 28341160.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    109. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimers Dement. 2017 Apr; 13(4):e1-e85. PMID: 28342697.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    110. Medication Use among Veterans across Health Care Systems. Appl Clin Inform. 2017 03 08; 8(1):235-249. PMID: 28271121.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    111. Fractional anisotropy derived from the diffusion tensor distribution function boosts power to detect Alzheimer's disease deficits. Magn Reson Med. 2017 Dec; 78(6):2322-2333. PMID: 28266059.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials. Clin Pharmacol Ther. 2017 Aug; 102(2):321-331. PMID: 28124478.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    113. Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease. Neurology. 2017 Mar 14; 88(11):1054-1061. PMID: 28188306.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    114. Independent value added by diffusion MRI for prediction of cognitive function in older adults. Neuroimage Clin. 2017; 14:166-173. PMID: 28180075.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    115. Genome-wide association study identifies MAPT locus influencing human plasma tau levels. Neurology. 2017 Feb 14; 88(7):669-676. PMID: 28100725.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    116. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017 01 18; 8:13624. PMID: 28098162.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    117. Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease. J Alzheimers Dis. 2017; 58(4):1245-1254. Deters KD, Risacher SL, Kim S, Nho K, West JD, Blennow K, Zetterberg H, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ. PMID: 28550246.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    118. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials. J Prev Alzheimers Dis. 2017; 4(2):116-124. PMID: 29186281.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    119. Editorial: Collaborative Efforts to Prevent Alzheimer's Disease. J Nutr Health Aging. 2017; 21(10):1072-1074. PMID: 29188862.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. Cross-Sectional Associations of Total Plasma Homocysteine with Cortical ß-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia. J Nutr Health Aging. 2017; 21(10):1075-1080. PMID: 29188863.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    121. A T1 and DTI fused 3D corpus callosum analysis in MCI subjects with high and low cardiovascular risk profile. Neuroimage Clin. 2017; 14:298-307. PMID: 28210541.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    122. The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimers Dement. 2017 May; 13(5):561-571. PMID: 27931796.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    123. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer. Support Care Cancer. 2017 03; 25(3):701-708. PMID: 27830395.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    124. The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions. Alzheimers Dement. 2016 11; 12(11):1113-1115. PMID: 27836052.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    125. Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure. J Clin Microbiol. 2016 12; 54(12):3028-3033. PMID: 27733634.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    126. Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala. Brain. 2016 12; 139(Pt 12):3253-3266. PMID: 27913407.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    127. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease. EMBO Mol Med. 2016 10; 8(10):1184-1196. PMID: 27534871.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    128. The Role of Cerebrovascular Disease in Amyloid Deposition. J Alzheimers Dis. 2016 10 04; 54(3):1015-1026. PMID: 27567803.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    129. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci. 2016 12; 19(12):1569-1582. PMID: 27694991.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    130. Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians. J Am Med Dir Assoc. 2016 10 01; 17(10):913-20. PMID: 27670604.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    131. Plasma tau in Alzheimer disease. Neurology. 2016 Oct 25; 87(17):1827-1835. PMID: 27694257.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    132. Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease. Neurobiol Aging. 2017 01; 49:204-213. PMID: 27836336.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    133. Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(9):e0163669. PMID: 27649320.
      View in: PubMed   Mentions: 1     Fields:    
    134. Cognitive and functional changes associated with Aß pathology and the progression to mild cognitive impairment. Neurobiol Aging. 2016 12; 48:172-181. PMID: 27710807.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    135. Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults. Neurobiol Aging. 2016 12; 48:48-52. PMID: 27639120.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    136. Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease. BMC Med Genomics. 2016 08 12; 9 Suppl 1:30. PMID: 27535542.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    137. Assessing risk for preclinical ß-amyloid pathology with APOE, cognitive, and demographic information. Alzheimers Dement (Amst). 2016; 4:76-84. PMID: 27722193.
      View in: PubMed   Mentions:
    138. Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers. J Alzheimers Dis. 2016 07 25; 54(1):99-107. PMID: 27472882.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    139. Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease. Alzheimers Dement. 2017 Mar; 13(3):225-235. PMID: 27432800.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    140. Decreased Self-Appraisal Accuracy on Cognitive Tests of Executive Functioning Is a Predictor of Decline in Mild Cognitive Impairment. Front Aging Neurosci. 2016; 8:120. PMID: 27458368.
      View in: PubMed   Mentions:
    141. The Reply. Am J Med. 2016 07; 129(7):e97. PMID: 27320719.
      View in: PubMed   Mentions:    Fields:    
    142. Medication management interventions in patients enrolled in GRACE Team Care. Geriatr Nurs. 2016 Sep - Oct; 37(5):371-375. PMID: 27344943.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    143. Relative impact of amyloid-ß, lacunes, and downstream imaging markers on cognitive trajectories. Brain. 2016 09; 139(Pt 9):2516-27. PMID: 27329772.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    144. The Development and Evaluation of an Online Healthcare Toolkit for Autistic Adults and their Primary Care Providers. J Gen Intern Med. 2016 10; 31(10):1180-9. PMID: 27271730.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    145. Which veterans enroll in a VA health information exchange program? J Am Med Inform Assoc. 2017 01; 24(1):96-105. PMID: 27274014.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol. 2016 06 01; 73(6):721-32. PMID: 27088965.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    147. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity. Neuroimage Clin. 2016; 11:802-812. PMID: 28050342.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    148. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016 Jun; 79(6):929-39. PMID: 27016429.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    149. Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort. Alzheimers Dement. 2016 09; 12(9):977-986. PMID: 27109039.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    150. Accelerating rates of cognitive decline and imaging markers associated with ß-amyloid pathology. Neurology. 2016 05 17; 86(20):1887-96. PMID: 27164667.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    151. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement. 2016 06; 12(6):645-53. PMID: 27079753.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    152. Opportunities to Enhance Value-Related Research in the U.S. Department of Veterans Affairs. J Gen Intern Med. 2016 Apr; 31 Suppl 1:78-83. PMID: 26951279.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(3):e0152082. PMID: 27010959.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    154. Neuroprotective Effects of Lithium in Human Brain? Food for Thought. Curr Alzheimer Res. 2016; 13(8):862-72. PMID: 26892290.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    155. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. J Prev Alzheimers Dis. 2016; 3(2):68-74. PMID: 29210442.
      View in: PubMed   Mentions: 11     Fields:    
    156. Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition. J Cereb Blood Flow Metab. 2016 Jan; 36(1):204-15. PMID: 26126864.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    157. Editorial: Statistical Signal Processing in the Analysis, Characterization and Detection of Alzheimer's Disease. Curr Alzheimer Res. 2016; 13(5):466-8. PMID: 27025774.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    158. Short-Term Medical Costs of a VHA Health Information Exchange: A CHEERS-Compliant Article. Medicine (Baltimore). 2016 Jan; 95(2):e2481. PMID: 26765453.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    159. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. JAMA Neurol. 2016 Jan; 73(1):60-7. PMID: 26524180.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    160. Health information exchanges--Unfulfilled promise as a data source for clinical research. Int J Med Inform. 2016 Mar; 87:1-9. PMID: 26806706.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    161. Relationship of regional brain ß-amyloid to gait speed. Neurology. 2016 Jan 05; 86(1):36-43. PMID: 26643548.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    162. Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly. Front Aging Neurosci. 2015; 7:221. PMID: 26648866.
      View in: PubMed   Mentions:
    163. Cascading network failure across the Alzheimer's disease spectrum. Brain. 2016 Feb; 139(Pt 2):547-62. PMID: 26586695.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    164. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-ß-Positive Subjects in the Alzheimer's Disease Continuum. Neurodegener Dis. 2016; 16(1-2):87-94. PMID: 26560336.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    165. MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials. Neurobiol Aging. 2016 Jan; 37:26-37. PMID: 26545631.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    166. Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding. Neurol Genet. 2015 Oct; 1(3):e22. PMID: 27066559.
      View in: PubMed   Mentions:
    167. Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia. Neurology. 2015 Nov 10; 85(19):1687-93. PMID: 26468407.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    168. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease. Brain. 2015 Nov; 138(Pt 11):3373-85. PMID: 26373605.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    169. Evidence for disrupted gray matter structural connectivity in posttraumatic stress disorder. Psychiatry Res. 2015 Nov 30; 234(2):194-201. PMID: 26419357.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    170. A Novel Design for Drug-Drug Interaction Alerts Improves Prescribing Efficiency. Jt Comm J Qual Patient Saf. 2015 Sep; 41(9):396-405. PMID: 26289234.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    171. Mapping 3-year changes in gray matter and metabolism in Aß-positive nondemented subjects. Neurobiol Aging. 2015 Nov; 36(11):2913-2924. PMID: 26476234.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    172. Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration. Neuroimage Clin. 2016; 12:332-40. PMID: 27547726.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    173. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. Brain. 2015 Oct; 138(Pt 10):3076-88. PMID: 26268530.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    174. Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution. AJNR Am J Neuroradiol. 2015 Sep; 36(9):1635-41. PMID: 26228889.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    175. Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2015 Jul; 11(7):730-3. PMID: 26194308.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    176. Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans. Alzheimers Dement. 2015 Jul; 11(7):734-9. PMID: 26194309.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    177. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimers Dement. 2015 Jul; 11(7):740-56. PMID: 26194310.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    178. The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans. Alzheimers Dement. 2015 Jul; 11(7):772-91. PMID: 26194312.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    179. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement. 2015 Jul; 11(7):792-814. PMID: 26194313.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    180. The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update. Alzheimers Dement. 2015 Jul; 11(7):850-9. PMID: 26194318.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    181. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimers Dement. 2015 Jul; 11(7):865-84. PMID: 26194320.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    182. Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings. Neurology. 2015 Jul 14; 85(2):144-53. PMID: 26085606.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    183. Reducing prescribing errors through creatinine clearance alert redesign. Am J Med. 2015 Oct; 128(10):1117-25. PMID: 26087048.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    184. Clinical effect of white matter network disruption related to amyloid and small vessel disease. Neurology. 2015 Jul 07; 85(1):63-70. PMID: 26062629.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    185. Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase. 2016; 22(1):76-83. PMID: 26040468.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    186. Rich club analysis in the Alzheimer's disease connectome reveals a relatively undisturbed structural core network. Hum Brain Mapp. 2015 Aug; 36(8):3087-103. PMID: 26037224.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    187. Evidence for age-associated cognitive decline from Internet game scores. Alzheimers Dement (Amst). 2015 Jun; 1(2):260-7. PMID: 27239508.
      View in: PubMed   Mentions:
    188. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 2015 Jun; 11(6):e1-120. PMID: 26073027.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    189. Circulating microRNA expression pattern separates patients with anti-neutrophil cytoplasmic antibody associated vasculitis from healthy controls. Clin Exp Rheumatol. 2015 Mar-Apr; 33(2 Suppl 89):S-64-71. PMID: 26016752.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    190. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis. Tuberculosis (Edinb). 2015 Jul; 95(4):415-20. PMID: 26022314.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    191. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015 Dec; 11(12):1417-1429. PMID: 25960448.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    192. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 ß-Amyloid Measures Across the Spectrum of Alzheimer Disease. JAMA Neurol. 2015 May; 72(5):571-81. PMID: 25822737.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    193. Predicting Reduction of Cerebrospinal Fluid ß-Amyloid 42 in Cognitively Healthy Controls. JAMA Neurol. 2015 May; 72(5):554-60. PMID: 25775167.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    194. Design and Evaluation of an Electronic Override Mechanism for Medication Alerts to Facilitate Communication Between Prescribers and Pharmacists. Ann Pharmacother. 2015 Jul; 49(7):761-9. PMID: 25855701.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    195. Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders. Nicotine Tob Res. 2016 Feb; 18(2):204-11. PMID: 25847292.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    196. SPECTRAL GRAPH THEORY AND GRAPH ENERGY METRICS SHOW EVIDENCE FOR THE ALZHEIMER'S DISEASE DISCONNECTION SYNDROME IN APOE-4 RISK GENE CARRIERS. Proc IEEE Int Symp Biomed Imaging. 2015 Apr; 2015:458-461. PMID: 26413205.
      View in: PubMed   Mentions:
    197. FEATURE SELECTION IMPROVES THE ACCURACY OF CLASSIFYING ALZHEIMER DISEASE USING DIFFUSION TENSOR IMAGES. Proc IEEE Int Symp Biomed Imaging. 2015 Apr; 2015:126-130. PMID: 26413201.
      View in: PubMed   Mentions:
    198. Implications for informatics given expanding access to care for Veterans and other populations. J Am Med Inform Assoc. 2015 Jul; 22(4):917-20. PMID: 25833394.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    199. Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia. Am J Geriatr Psychiatry. 2016 Feb; 24(2):126-35. PMID: 26238228.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    200. Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease. Ann Clin Transl Neurol. 2015 May; 2(5):534-47. PMID: 26000325.
      View in: PubMed   Mentions: 7     Fields:    
    201. Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease. Neuroimage. 2015 Jun; 113:61-9. PMID: 25797830.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    202. Improved power for characterizing longitudinal amyloid-ß PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. J Nucl Med. 2015 Apr; 56(4):560-6. PMID: 25745091.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    203. Apolipoprotein e4 is associated with lower brain volume in cognitively normal Chinese but not white older adults. PLoS One. 2015; 10(3):e0118338. PMID: 25738563.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    204. Brain amyloid-ß burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly. J Neurosci. 2015 Feb 18; 35(7):3240-7. PMID: 25698758.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    205. Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol. 2015 Mar; 77(3):547-52. PMID: 25559091.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    206. Brain structure and function as mediators of the effects of amyloid on memory. Neurology. 2015 Mar 17; 84(11):1136-44. PMID: 25681451.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    207. Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's Disease Neuroimaging Initiative. AJNR Am J Neuroradiol. 2015 Apr; 36(4):653-60. PMID: 25614473.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    208. Common genetic variants influence human subcortical brain structures. Nature. 2015 Apr 09; 520(7546):224-9. PMID: 25607358.
      View in: PubMed   Mentions: 245     Fields:    Translation:Humans
    209. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures. Neurology. 2015 Feb 17; 84(7):729-37. PMID: 25609767.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    210. PBMC telomerase activity, but not leukocyte telomere length, correlates with hippocampal volume in major depression. Psychiatry Res. 2015 Apr 30; 232(1):58-64. PMID: 25773002.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    211. Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. Cell Rep. 2015 Jan 20; 10(3):359-369. PMID: 25600871.
      View in: PubMed   Mentions: 41     Fields:    
    212. Towards Constructing a New Taxonomy for Psychiatry Using Self-reported Symptoms. Stud Health Technol Inform. 2015; 216:736-40. PMID: 26262149.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    213. Cerebrospinal fluid a-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis. 2015; 43(3):1007-16. PMID: 25125463.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    214. Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort. Dement Geriatr Cogn Disord. 2015; 39(3-4):154-66. PMID: 25547651.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    215. Independent information from cerebrospinal fluid amyloid-ß and florbetapir imaging in Alzheimer's disease. Brain. 2015 Mar; 138(Pt 3):772-83. PMID: 25541191.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    216. Algebraic connectivity of brain networks shows patterns of segregation leading to reduced network robustness in Alzheimer's disease. Comput Diffus MRI (2014). 2014; 2014:55-64. PMID: 26640830.
      View in: PubMed   Mentions:
    217. The role of carotid intima-media thickness in predicting longitudinal cognitive function in an older adult cohort. Cerebrovasc Dis. 2014; 38(6):441-7. PMID: 25502351.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    218. The transitional association between ß-amyloid pathology and regional brain atrophy. Alzheimers Dement. 2015 Oct; 11(10):1171-9. PMID: 25499535.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    219. Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement. Neuroimage. 2015 Feb 15; 107:46-53. PMID: 25481794.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    220. Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans. Psychoneuroendocrinology. 2015 Jan; 51:557-66. PMID: 25465168.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    221. FASTKD2 is associated with memory and hippocampal structure in older adults. Mol Psychiatry. 2015 Oct; 20(10):1197-204. PMID: 25385369.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    222. Does MRI scan acceleration affect power to track brain change? Neurobiol Aging. 2015 Jan; 36 Suppl 1:S167-77. PMID: 25444601.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    223. Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain. 2014 Nov; 137(Pt 11):3047-60. PMID: 25273996.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    224. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimers Dement. 2015 May; 11(5):549-60. PMID: 25282381.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    225. Thickness network features for prognostic applications in dementia. Neurobiol Aging. 2015 Jan; 36 Suppl 1:S91-S102. PMID: 25444603.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    226. Brain atrophy rates in first degree relatives at risk for Alzheimer's. Neuroimage Clin. 2014; 6:340-6. PMID: 25379448.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    227. The BrainHealthRegistry.org: Using the Internet for identification, assessment, screening, recruitment, and longitudinal monitoring of subjects for neuroscience and Alzheimer's disease studies. J Prev Alzheimers Dis. 2014 Sep; 1(2):59-61. Weiner MW. PMID: 28620591.
      View in: PubMed   Mentions:    Fields:    
    228. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. JAMA Neurol. 2014 Sep; 71(9):1111-22. PMID: 25069482.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    229. Connectivity network measures predict volumetric atrophy in mild cognitive impairment. Neurobiol Aging. 2015 Jan; 36 Suppl 1:S113-20. PMID: 25444606.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    230. Mapping ventricular expansion onto cortical gray matter in older adults. Neurobiol Aging. 2015 Jan; 36 Suppl 1:S32-41. PMID: 25311280.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    231. Empowering imaging biomarkers of Alzheimer's disease. Neurobiol Aging. 2015 Jan; 36 Suppl 1:S69-80. PMID: 25260848.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    232. Seemingly unrelated regression empowers detection of network failure in dementia. Neurobiol Aging. 2015 Jan; 36 Suppl 1:S103-12. PMID: 25257986.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    233. Genome-wide interaction analysis reveals replicated epistatic effects on brain structure. Neurobiol Aging. 2015 Jan; 36 Suppl 1:S151-8. PMID: 25264344.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    234. Diffusion weighted imaging-based maximum density path analysis and classification of Alzheimer's disease. Neurobiol Aging. 2015 Jan; 36 Suppl 1:S132-40. PMID: 25444597.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    235. Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment. Neurobiol Aging. 2015 Jan; 36(1):273-82. PMID: 25175807.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    236. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014 Aug; 71(8):961-70. PMID: 24886908.
      View in: PubMed   Mentions: 161     Fields:    Translation:Humans
    237. Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients. Alzheimers Dement. 2015 May; 11(5):494-503.e3. PMID: 25048578.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    238. Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Ann Clin Transl Neurol. 2014 Aug; 1(8):534-43. PMID: 25356425.
      View in: PubMed   Mentions: 27     Fields:    
    239. Widespread white matter degeneration preceding the onset of dementia. Alzheimers Dement. 2015 May; 11(5):485-493.e2. PMID: 25035154.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    240. History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress. Drug Alcohol Depend. 2014 Sep 01; 142:262-8. PMID: 25037769.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    241. Cortisol, cytokines, and hippocampal volume interactions in the elderly. Front Aging Neurosci. 2014; 6:153. PMID: 25071562.
      View in: PubMed   Mentions:
    242. Vascular risk and Aß interact to reduce cortical thickness in AD vulnerable brain regions. Neurology. 2014 Jul 01; 83(1):40-7. PMID: 24907234.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    243. Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure. Neurobiol Aging. 2014 Nov; 35(11):2504-2513. PMID: 24997672.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    244. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S122-45. PMID: 24924665.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansAnimals
    245. Are hippocampal size differences in posttraumatic stress disorder mediated by sleep pathology? Alzheimers Dement. 2014 Jun; 10(3 Suppl):S146-54. PMID: 24924666.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    246. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S226-35. PMID: 24924673.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    247. Military Risk Supplement. Preface. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S92-3. PMID: 24924678.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    248. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 2014 Jun; 8(2):153-82. PMID: 24399358.
      View in: PubMed   Mentions: 177     Fields:    Translation:Humans
    249. Emerging ß-amyloid pathology and accelerated cortical atrophy. JAMA Neurol. 2014 Jun; 71(6):725-34. PMID: 24781145.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    250. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav. 2014 Jun; 8(2):183-207. PMID: 24092460.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    251. MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA. J Prev Alzheimers Dis. 2014 Jun; 1(1):13-22. PMID: 26594639.
      View in: PubMed   Mentions: 63     Fields:    
    252. APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years. Neurobiol Aging. 2014 Nov; 35(11):2479-2485. PMID: 24929969.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    253. Three-Class Differential Diagnosis among Alzheimer Disease, Frontotemporal Dementia, and Controls. Front Neurol. 2014; 5:71. PMID: 24860545.
      View in: PubMed   Mentions:
    254. Mapping of ApoE4 Related White Matter Damage using Diffusion MRI. Proc SPIE Int Soc Opt Eng. 2014 Apr 09; 9039:90390H. PMID: 25076830.
      View in: PubMed   Mentions:
    255. Synergistic effects of ischemia and ß-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment. JAMA Psychiatry. 2014 Apr; 71(4):412-22. PMID: 24554306.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    256. Applying human factors principles to alert design increases efficiency and reduces prescribing errors in a scenario-based simulation. J Am Med Inform Assoc. 2014 Oct; 21(e2):e287-96. PMID: 24668841.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    257. Estimating long-term multivariate progression from short-term data. Alzheimers Dement. 2014 Oct; 10(5 Suppl):S400-10. PMID: 24656849.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    258. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Neuroimage Clin. 2014; 4:508-16. PMID: 24818077.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    259. Association of brain amyloid-ß with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain. 2014 May; 137(Pt 5):1550-61. PMID: 24625697.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    260. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun. 2014 Mar 06; 2:26. PMID: 24602322.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    261. Associations between subjective sleep quality and brain volume in Gulf War veterans. Sleep. 2014 Mar 01; 37(3):445-52. PMID: 24587566.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    262. Multimodal MRI-based Imputation of the Aß+ in Early Mild Cognitive Impairment. Ann Clin Transl Neurol. 2014 Mar; 1(3):160-170. PMID: 24729983.
      View in: PubMed   Mentions: 10     Fields:    
    263. Denoising diffusion-weighted magnitude MR images using rank and edge constraints. Magn Reson Med. 2014 Mar; 71(3):1272-84. PMID: 23568755.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    264. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology. 2014 Mar 11; 82(10):835-41. PMID: 24523480.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    265. Quantifying anatomical shape variations in neurological disorders. Med Image Anal. 2014 Apr; 18(3):616-33. PMID: 24667299.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    266. Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical type. Eur J Neurol. 2014 May; 21(5):744-51. PMID: 24495089.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    267. Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression. PLoS One. 2014; 9(1):e87747. PMID: 24498184.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    268. Cortical thickness mediates the effect of ß-amyloid on episodic memory. Neurology. 2014 Mar 04; 82(9):761-7. PMID: 24489134.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    269. Neural substrates of socioemotional self-awareness in neurodegenerative disease. Brain Behav. 2014 Mar; 4(2):201-14. PMID: 24683513.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    270. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease. Neuroimage Clin. 2014; 4:461-72. PMID: 24634832.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    271. CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathol. 2014 May; 127(5):621-32. PMID: 24385135.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    272. Is Alzheimer's Disease Drug Development Broken? What Must Be Improved. J Prev Alzheimers Dis. 2014; 1(1):40-45. PMID: 29261219.
      View in: PubMed   Mentions: 3     Fields:    
    273. EU./U.S. CTAD Task Force on Alzheimer's Trial Populations. J Prev Alzheimers Dis. 2014; 1(2):110-116. Vellas B, Sampaio C, Bateman R, Boxer A, Carrillo MC, Cummings J, Dubois B, Hampel H, Katz R, Khachaturian Z, Gauthier S, Johnson K, Karlawish J, Mintun M, Petersen R, Rafii M, Robert P, Schneider LS, Siemers E, Sperling R, Tariot P, Touchon J, Weiner M, Andrieu S, Aisen P. PMID: 29255837.
      View in: PubMed   Mentions:    Fields:    
    274. Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10(1):109-14. PMID: 24365657.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    275. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers. J Alzheimers Dis. 2014; 40(4):877-86. PMID: 24577457.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    276. Effects of baseline CSF a-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. PLoS One. 2013; 8(12):e85443. PMID: 24392009.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    277. A single nucleotide polymorphism associated with reduced alcohol intake in the RASGRF2 gene predicts larger cortical volumes but faster longitudinal ventricular expansion in the elderly. Front Aging Neurosci. 2013; 5:93. PMID: 24409144.
      View in: PubMed   Mentions:
    278. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):E4502-9. PMID: 24194552.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    279. Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects. Neuroimage Clin. 2014; 4:45-52. PMID: 24286024.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    280. Military risk factors for cognitive decline, dementia and Alzheimer's disease. Curr Alzheimer Res. 2013 Nov; 10(9):907-30. PMID: 23906002.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    281. Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis. PLoS One. 2013; 8(10):e75602. PMID: 24130724.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    282. Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathol Commun. 2013 Oct 09; 1:65. PMID: 24252435.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    283. Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. Neurobiol Aging. 2014 Mar; 35(3):614-22. PMID: 24094581.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    284. Neuroimaging predictors of brain amyloidosis in mild cognitive impairment. Ann Neurol. 2013 Aug; 74(2):188-98. PMID: 23686534.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    285. Early indications of future cognitive decline: stable versus declining controls. PLoS One. 2013; 8(9):e74062. PMID: 24040166.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    286. CSF protein biomarkers predicting longitudinal reduction of CSF ß-amyloid42 in cognitively healthy elders. Transl Psychiatry. 2013 Aug 20; 3:e293. PMID: 23962923.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    287. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2013 Sep; 9(5):e111-94. PMID: 23932184.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    288. Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment. Neurobiol Aging. 2014 Jan; 35(1):254-60. PMID: 23932881.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    289. Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol. 2013 Aug; 74(2):199-208. PMID: 23686697.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    290. Imaging markers for Alzheimer disease: which vs how. Neurology. 2013 Jul 30; 81(5):487-500. PMID: 23897875.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    291. Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin. 2013; 3:180-95. PMID: 24179862.
      View in: PubMed   Mentions: 88     Fields:    
    292. Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel. PLoS One. 2013; 8(7):e70269. PMID: 23894628.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    293. The future of blood-based biomarkers for Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10(1):115-31. PMID: 23850333.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    294. Military risk factors for Alzheimer's disease. Alzheimers Dement. 2013 Jul; 9(4):445-51. PMID: 23809365.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    295. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 2013 Jul; 9(4):438-44. PMID: 23809364.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    296. Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics. Mol Psychiatry. 2013 Jul; 18(7):739. PMID: 23787478.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    297. Regional cerebral volumes in veterans with current versus remitted posttraumatic stress disorder. Psychiatry Res. 2013 Sep 30; 213(3):193-201. PMID: 23816189.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    298. Locally linear embedding (LLE) for MRI based Alzheimer's disease classification. Neuroimage. 2013 Dec; 83:148-57. PMID: 23792982.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    299. Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin. 2013; 2:827-35. PMID: 24179834.
      View in: PubMed   Mentions: 16     Fields:    
    300. Effects of APOE e4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment. Neurobiol Aging. 2013 Nov; 34(11):2482-7. PMID: 23769398.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    301. Grey and white matter abnormalities in temporal lobe epilepsy with and without mesial temporal sclerosis. J Neurol. 2013 Sep; 260(9):2320-9. PMID: 23754695.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    302. Associations between white matter hyperintensities and ß amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One. 2013; 8(6):e65175. PMID: 23762308.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    303. MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements. PLoS One. 2013; 8(6):e66367. PMID: 23762488.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    304. Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N?=?1345 young and elderly subjects. Brain Imaging Behav. 2013 Jun; 7(2):102-15. Hibar DP, Stein JL, Ryles AB, Kohannim O, Jahanshad N, Medland SE, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Saykin AJ, Jack CR, Weiner MW, Toga AW, Thompson PM. PMID: 22903471.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    305. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia. Eur J Nucl Med Mol Imaging. 2013 Sep; 40(9):1394-405. PMID: 23715905.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    306. Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer. Ann Oncol. 2013 Aug; 24(8):1994-9. PMID: 23670096.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    307. Spontaneous brain activity in combat related PTSD. Neurosci Lett. 2013 Jun 28; 547:1-5. PMID: 23643995.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    308. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry. 2013 Jul; 18(7):781-7. PMID: 23608917.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    309. Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample. Genomics. 2013 Aug; 102(2):112-22. PMID: 23583670.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    310. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci. 2013; 5:11. PMID: 23554593.
      View in: PubMed   Mentions:
    311. The aging brain and cognition: contribution of vascular injury and aß to mild cognitive dysfunction. JAMA Neurol. 2013 Apr; 70(4):488-95. PMID: 23400560.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    312. Association of plasma and cortical amyloid beta is modulated by APOE e4 status. Alzheimers Dement. 2014 Jan; 10(1):e9-e18. PMID: 23541187.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    313. Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology. 2013 Mar 26; 80(13):1194-201. PMID: 23486873.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    314. Design of a medication reconciliation application: facilitating clinician-focused decision making with data from multiple sources. Appl Clin Inform. 2013; 4(1):110-25. PMID: 23650492.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    315. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol. 2013 May; 73(5):584-93. PMID: 23495089.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    316. Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. Proc Natl Acad Sci U S A. 2013 Mar 19; 110(12):4768-73. PMID: 23471985.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCellsCTClinical Trials
    317. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 2013 Mar 01; 70(3):320-5. PMID: 23599929.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    318. A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations. Hum Brain Mapp. 2014 Apr; 35(4):1226-36. PMID: 23427138.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    319. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry. 2014 Mar; 19(3):351-7. PMID: 23419831.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    320. Voxel-wise co-analysis of macro- and microstructural brain alteration in mild cognitive impairment and Alzheimer's disease using anatomical and diffusion MRI. J Neuroimaging. 2014 Sep-Oct; 24(5):435-43. PMID: 23421601.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    321. Voxelwise multivariate analysis of multimodality magnetic resonance imaging. Hum Brain Mapp. 2014 Mar; 35(3):831-46. PMID: 23408378.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    322. The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment. Am J Geriatr Psychiatry. 2013 Sep; 21(9):906-14. PMID: 23567388.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    323. Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response. Am J Geriatr Psychiatry. 2013 Aug; 21(8):794-802. PMID: 23567394.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    324. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013 Feb; 12(2):207-16. PMID: 23332364.
      View in: PubMed   Mentions: 1050     Fields:    Translation:Humans
    325. Focal hemosiderin deposits and ß-amyloid load in the ADNI cohort. Alzheimers Dement. 2013 Oct; 9(5 Suppl):S116-23. PMID: 23375568.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    326. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain. 2013 Mar; 136(Pt 3):844-58. PMID: 23358601.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    327. Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. Neuroreport. 2013 Jan 23; 24(2):58-62. PMID: 23238164.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    328. Dementia in 2012: Further insights into Alzheimer disease pathogenesis. Nat Rev Neurol. 2013 Feb; 9(2):65-6. PMID: 23338285.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    329. Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features. Neuroimage. 2013 Apr 15; 70:386-401. PMID: 23296188.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    330. Exhaustive search of the SNP-sNP interactome identifies epistatic effects on brain volume in two cohorts. Med Image Comput Comput Assist Interv. 2013; 16(Pt 3):600-7. PMID: 24505811.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    331. MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes. J Alzheimers Dis. 2013; 33(2):431-44. PMID: 22976075.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    332. Breakdown of brain connectivity between normal aging and Alzheimer's disease: a structural k-core network analysis. Brain Connect. 2013; 3(4):407-22. PMID: 23701292.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    333. Alzheimer's Disease Disrupts Rich Club Organization in Brain Connectivity Networks. Proc IEEE Int Symp Biomed Imaging. 2013; 266-269. PMID: 24953139.
      View in: PubMed   Mentions:
    334. Mapping Dynamic Changes in Ventricular Volume onto Baseline Cortical Surfaces in Normal Aging, MCI, and Alzheimer's Disease. Multimodal Brain Image Anal (2013). 2013; 8159:84-94. PMID: 25152934.
      View in: PubMed   Mentions:
    335. A Graph-Based Integration of Multimodal Brain Imaging Data for the Detection of Early Mild Cognitive Impairment (E-MCI). Multimodal Brain Image Anal (2013). 2013; 8159:159-169. PMID: 25383392.
      View in: PubMed   Mentions:
    336. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 2012 Dec; 6(4):502-16. PMID: 22782295.
      View in: PubMed   Mentions: 150     Fields:    Translation:Humans
    337. Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks. Brain Imaging Behav. 2012 Dec; 6(4):634-48. PMID: 22865056.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    338. Lessons from a randomised clinical trial for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2012 Dec; 16(12):1582-7. PMID: 23131255.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    339. Design and implementation of a hospital-based usability laboratory: insights from a Department of Veterans Affairs laboratory for health information technology. Jt Comm J Qual Patient Saf. 2012 Dec; 38(12):531-40. PMID: 23240261.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    340. Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly. Neurobiol Aging. 2013 Apr; 34(4):1221-30. PMID: 23182131.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    341. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage. 2013 Feb 01; 66:648-61. PMID: 23153970.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    342. Harnessing a health information exchange to identify surgical device adverse events for urogynecologic mesh. AMIA Annu Symp Proc. 2012; 2012:1109-18. PMID: 23304387.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    343. Cardiovascular risk factors, cortisol, and amyloid-ß deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2012 Nov; 8(6):483-9. PMID: 23102118.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    344. Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking. Alzheimers Dement. 2012 Nov; 8(6):513-9. PMID: 23102121.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    345. Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement. 2013 May; 9(3):332-7. PMID: 23110865.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    346. Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. Neuroimage Clin. 2012; 1(1):179-87. PMID: 24179750.
      View in: PubMed   Mentions: 11     Fields:    
    347. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol. 2012 Oct; 72(4):578-86. PMID: 23109153.
      View in: PubMed   Mentions: 210     Fields:    Translation:HumansPHPublic Health
    348. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond). 2012 Oct 01; 2(10):975-984. PMID: 23139856.
      View in: PubMed   Mentions:
    349. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke. 2012 Nov; 43(11):2865-70. PMID: 22984010.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    350. Pilot expertise and hippocampal size: associations with longitudinal flight simulator performance. Aviat Space Environ Med. 2012 Sep; 83(9):850-7. PMID: 22946348.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    351. Different associations of white matter lesions with depression and cognition. BMC Neurol. 2012 Aug 25; 12:83. PMID: 22920586.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    352. Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression. Front Neurosci. 2012; 6:115. PMID: 22888310.
      View in: PubMed   Mentions:
    353. When 'technically preventable' alerts occur, the design--not the prescriber--has failed. J Am Med Inform Assoc. 2012 Nov-Dec; 19(6):1119; author reply 1119-20. PMID: 22847307.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    354. Worldwide Alzheimer's disease neuroimaging initiative. Alzheimers Dement. 2012 Jul; 8(4):337-42. PMID: 22748939.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    355. Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol. 2012 Jul; 69(7):856-67. PMID: 22409939.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    356. Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav. 2012 Jul; 2(4):435-42. PMID: 22950047.
      View in: PubMed   Mentions: 37     Fields:    
    357. COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures. Neurology. 2012 May 22; 78(21):1663-9. PMID: 22573634.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    358. Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers. Clin Pharmacol Ther. 2012 May; 91(5):881-8. PMID: 22472995.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    359. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012 Apr 15; 44(5):552-61. PMID: 22504417.
      View in: PubMed   Mentions: 269     Fields:    Translation:HumansCells
    360. Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. J Nutr Health Aging. 2012 Apr; 16(4):339-45. PMID: 22499454.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    361. A network diffusion model of disease progression in dementia. Neuron. 2012 Mar 22; 73(6):1204-15. PMID: 22445347.
      View in: PubMed   Mentions: 185     Fields:    Translation:Humans
    362. Improved diffusion imaging through SNR-enhancing joint reconstruction. Magn Reson Med. 2013 Jan; 69(1):277-89. PMID: 22392528.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    363. White matter alterations in cognitively normal apoE e2 carriers: insight into Alzheimer resistance? AJNR Am J Neuroradiol. 2012 Aug; 33(7):1392-7. PMID: 22383234.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    364. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav. 2012 Mar; 6(1):1-15. Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR, Weiner MW, Saykin AJ. PMID: 21901424.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    365. Prediction of conversion from mild cognitive impairment to Alzheimer disease based on bayesian data mining with ensemble learning. Neuroradiol J. 2012 Mar; 25(1):5-16. PMID: 24028870.
      View in: PubMed   Mentions: 5     Fields:    
    366. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90. PMID: 22343285.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    367. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry. 2012 May 01; 71(9):814-21. PMID: 22322105.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    368. Aß Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2012 Feb; 39(2):209-19. PMID: 22218879.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    369. Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI. Neuroimage. 2012 Apr 02; 60(2):1266-79. PMID: 22306801.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    370. Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc. 2012 Mar; 60(3):499-504. PMID: 22283410.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    371. Incremental dementia-related expenditures in a medicaid population. Am J Geriatr Psychiatry. 2012 Jan; 20(1):73-83. PMID: 22183012.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    372. PREDICTING TEMPORAL LOBE VOLUME ON MRI FROM GENOTYPES USING L(1)-L(2) REGULARIZED REGRESSION. Proc IEEE Int Symp Biomed Imaging. 2012; 1160-1163. PMID: 22903144.
      View in: PubMed   Mentions:
    373. SMALL WORLD NETWORK MEASURES PREDICT WHITE MATTER DEGENERATION IN PATIENTS WITH EARLY-STAGE MILD COGNITIVE IMPAIRMENT. Proc IEEE Int Symp Biomed Imaging. 2012; 1405-1408. PMID: 22903203.
      View in: PubMed   Mentions:
    374. Arterial spin labeling MRI study of age and gender effects on brain perfusion hemodynamics. Magn Reson Med. 2012 Sep; 68(3):912-22. PMID: 22139957.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    375. The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage. 2012 Feb 15; 59(4):4196-200. PMID: 22100665.
      View in: PubMed   Mentions: 4     Fields:    
    376. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2012 Feb; 8(1 Suppl):S1-68. PMID: 22047634.
      View in: PubMed   Mentions: 207     Fields:    Translation:Humans
    377. Cerebrovascular disease, ß-amyloid, and cognition in aging. Neurobiol Aging. 2012 May; 33(5):1006.e25-36. Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, Chui HC, Jagust WJ. PMID: 22048124.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    378. CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex. 2012 Sep; 22(9):1993-2004. PMID: 22038908.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    379. Executive dysfunction in frontotemporal dementia is related to abnormalities in frontal white matter tracts. J Neurol. 2012 Jun; 259(6):1071-80. PMID: 22037958.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    380. MRI patterns of atrophy and hypoperfusion associations across brain regions in frontotemporal dementia. Neuroimage. 2012 Feb 01; 59(3):2098-109. PMID: 22036676.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    381. Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology. 2011 Sep 27; 77(13):1263-71. PMID: 21917762.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    382. Prevention trials in Alzheimer's disease: an EU-US task force report. Prog Neurobiol. 2011 Dec; 95(4):594-600. PMID: 21925234.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    383. Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net. Multimodal Brain Image Anal (2011). 2011 Sep; 7012:27-34. PMID: 27054198.
      View in: PubMed   Mentions:
    384. Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease. J Mol Neurosci. 2011 Nov; 45(3):594-608. PMID: 21881831.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    385. Impact of apolipoprotein E4-cerebrospinal fluid ß-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement. 2011 Sep; 7(5):514-20. PMID: 21889115.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    386. Perioperative cognitive decline in the aging population. Mayo Clin Proc. 2011 Sep; 86(9):885-93. PMID: 21878601.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    387. Impact of methodologic choice for automatic detection of different aspects of brain atrophy by using temporal lobe epilepsy as a model. AJNR Am J Neuroradiol. 2011 Oct; 32(9):1669-76. PMID: 21852375.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    388. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord. 2012 Jan; 27(1):90-7. PMID: 21850668.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    389. Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol. 2011 Dec; 68(12):1526-35. PMID: 21825215.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    390. Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Arch Gen Psychiatry. 2011 Aug; 68(8):853-61. PMID: 21810649.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    391. Clinicopathological correlations in corticobasal degeneration. Ann Neurol. 2011 Aug; 70(2):327-40. Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ, Huang EJ, Trojanowski JQ, Growdon ME, Jang JY, Sidhu M, See TM, Karydas AM, Gorno-Tempini ML, Boxer AL, Weiner MW, Geschwind MD, Rankin KP, Miller BL. PMID: 21823158.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    392. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol. 2011 Aug; 68(8):1040-8. PMID: 21825241.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    393. The relationship between Gulf War illness, brain N-acetylaspartate, and post-traumatic stress disorder. Mil Med. 2011 Aug; 176(8):896-902. Weiner MW, Meyerhoff DJ, Neylan TC, Hlavin J, Ramage ER, McCoy D, Studholme C, Cardenas V, Marmar C, Truran D, Chu PW, Kornak J, Furlong CE, McCarthy C. PMID: 21882779.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    394. Factors affecting Aß plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol. 2011 Oct; 122(4):401-13. Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM. PMID: 21805181.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    395. Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials. Alzheimers Dement. 2011 Nov; 7(6):602-610.e2. PMID: 21745761.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    396. Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study. Amyotroph Lateral Scler. 2011 Nov; 12(6):421-9. PMID: 21745124.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    397. Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry. 2012 Apr; 27(4):355-63. PMID: 21744390.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    398. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011 Oct 01; 58(3):818-28. PMID: 21763442.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    399. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement. 2011 Jul; 7(4):474-485.e4. PMID: 21784356.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    400. AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials. Alzheimers Dement. 2011 Jul; 7(4):e109-17. Vellas B, Pesce A, Robert PH, Aisen PS, Ancoli-Israel S, Andrieu S, Cedarbaum J, Dubois B, Siemers E, Spire JP, Weiner MW, May TS. PMID: 21784343.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    401. Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: a study at 4T. Neurotoxicology. 2011 Dec; 32(6):814-22. Chao LL, Abadjian L, Hlavin J, Meyerhoff DJ, Weiner MW. PMID: 21741405.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    402. Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia. Int J Alzheimers Dis. 2011; 2011:546871. Zhang Y, Schuff N, Ching C, Tosun D, Zhan W, Nezamzadeh M, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW. PMID: 21760989.
      View in: PubMed   Mentions:
    403. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci. 2011 Aug; 34(8):430-42. PMID: 21696834.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    404. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug; 33(8):1599-608. PMID: 21684041.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    405. Changes in brain anatomy during the course of posttraumatic stress disorder. Psychiatry Res. 2011 Aug 30; 193(2):93-100. PMID: 21683556.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    406. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011 Oct; 68(10):1257-66. PMID: 21670386.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    407. Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport. 2011 Jun 11; 22(8):391-5. Rajagopalan P, Hua X, Toga AW, Jack CR, Weiner MW, Thompson PM. PMID: 21512418.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    408. Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease. Alzheimers Dement. 2011 Jul; 7(4):425-35. PMID: 21646051.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    409. Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study. Int J Alzheimers Dis. 2011; 2011:729478. Swaminathan S, Kim S, Shen L, Risacher SL, Foroud T, Pankratz N, Potkin SG, Huentelman MJ, Craig DW, Weiner MW, Saykin AJ. PMID: 21660214.
      View in: PubMed   Mentions:
    410. Commentary on "Biomarkers in Alzheimer's disease drug development." The view from Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2011 May; 7(3):e45-7. Weiner MW. PMID: 21575867.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    411. The relative efficiency of time-to-threshold and rate of change in longitudinal data. Contemp Clin Trials. 2011 Sep; 32(5):685-93. PMID: 21554992.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    412. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 2011 May 24; 76(21):1789-96. Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD. PMID: 21525424.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    413. Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search. Mol Psychiatry. 2011 Sep; 16(9):927-37, 881. Stein JL, Hibar DP, Madsen SK, Khamis M, McMahon KL, de Zubicaray GI, Hansell NK, Montgomery GW, Martin NG, Wright MJ, Saykin AJ, Jack CR, Weiner MW, Toga AW, Thompson PM. PMID: 21502949.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    414. MRI shows more severe hippocampal atrophy and shape deformation in hippocampal sclerosis than in Alzheimer's disease. Int J Alzheimers Dis. 2011 Apr 11; 2011:483972. Zarow C, Wang L, Chui HC, Weiner MW, Csernansky JG. PMID: 21547227.
      View in: PubMed   Mentions:
    415. Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage. 2011 Jun 15; 56(4):1875-91. Hibar DP, Stein JL, Kohannim O, Jahanshad N, Saykin AJ, Shen L, Kim S, Pankratz N, Foroud T, Huentelman MJ, Potkin SG, Jack CR, Weiner MW, Toga AW, Thompson PM. PMID: 21497199.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    416. Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition. Brain. 2011 May; 134(Pt 5):1479-92. PMID: 21478184.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    417. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology. 2011 Jun; 259(3):844-51. PMID: 21467255.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    418. Different structural correlates for verbal memory impairment in temporal lobe epilepsy with and without mesial temporal lobe sclerosis. Hum Brain Mapp. 2012 Feb; 33(2):489-99. Mueller SG, Laxer KD, Scanlon C, Garcia P, McMullen WJ, Loring DW, Meador KJ, Weiner MW. PMID: 21438080.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    419. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain. 2011 Apr; 134(Pt 4):1077-88. Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW. PMID: 21429865.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    420. Evidence for functional specialization of hippocampal subfields detected by MR subfield volumetry on high resolution images at 4 T. Neuroimage. 2011 Jun 01; 56(3):851-7. Mueller SG, Chao LL, Berman B, Weiner MW. PMID: 21419225.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    421. Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010. Alzheimers Dement. 2011 Mar; 7(2):127-32. Khachaturian ZS, Petersen RC, Snyder PJ, Khachaturian AS, Aisen P, de Leon M, Greenberg BD, Kukull W, Maruff P, Sperling RA, Stern Y, Touchon J, Vellas B, Andrieu S, Weiner MW, Carrillo MC, Bain LJ. PMID: 21414553.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    422. Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry. Neuroimage. 2011 Jul 01; 57(1):5-14. PMID: 21320612.
      View in: PubMed   Mentions: 46     Fields:    
    423. Cortical thinning related to periventricular and deep white matter hyperintensities. Neurobiol Aging. 2012 Jul; 33(7):1156-67. Seo SW, Lee JM, Im K, Park JS, Kim SH, Kim ST, Ahn HJ, Chin J, Cheong HK, Weiner MW, Na DL. PMID: 21316813.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    424. Transforming cerebrospinal fluid Aß42 measures into calculated Pittsburgh Compound B units of brain Aß amyloid. Alzheimers Dement. 2011 Mar; 7(2):133-41. Weigand SD, Vemuri P, Wiste HJ, Senjem ML, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, Jack CR. PMID: 21282074.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    425. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage. 2011 May 01; 56(1):52-60. PMID: 21276856.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    426. Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotroph Lateral Scler. 2011 Jan; 12(1):52-8. PMID: 21271791.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    427. Implementing dementia care models in primary care settings: The Aging Brain Care Medical Home. Aging Ment Health. 2011 Jan; 15(1):5-12. Callahan CM, Boustani MA, Weiner M, Beck RA, Livin LR, Kellams JJ, Willis DR, Hendrie HC. PMID: 20945236.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    428. Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol. 2011 Jan; 68(1):58-66. Schneider LS, Insel PS, Weiner MW. PMID: 21220675.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    429. Hippocampal surface mapping of genetic risk factors in AD via sparse learning models. Med Image Comput Comput Assist Interv. 2011; 14(Pt 2):376-83. PMID: 21995051.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    430. Imaging the Alzheimer brain. J Alzheimers Dis. 2011; 26 Suppl 3:1-27. Ashford JW, Salehi A, Furst A, Bayley P, Frisoni GB, Jack CR, Sabri O, Adamson MM, Coburn KL, Olichney J, Schuff N, Spielman D, Edland SD, Black S, Rosen A, Kennedy D, Weiner M, Perry G. PMID: 21971448.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    431. Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data. J Alzheimers Dis. 2011; 26 Suppl 3:77-90. PMID: 21971452.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    432. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging. 2012 Jul; 33(7):1203-14. PMID: 21159408.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    433. Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol. 2011 Dec; 95(4):579-93. Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B. PMID: 21130138.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    434. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology. 2011 Jan 04; 76(1):69-79. Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ. PMID: 21123754.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    435. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol Psychiatry. 2011 Nov; 16(11):1130-8. Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S. PMID: 21116278.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    436. Hippocampal volume differences in Gulf War veterans with current versus lifetime posttraumatic stress disorder symptoms. Biol Psychiatry. 2011 Mar 15; 69(6):541-8. Apfel BA, Ross J, Hlavin J, Meyerhoff DJ, Metzler TJ, Marmar CR, Weiner MW, Schuff N, Neylan TC. PMID: 21094937.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    437. BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group. Blood. 2011 Mar 03; 117(9):2596-603. Kelly KM, Sposto R, Hutchinson R, Massey V, McCarten K, Perkins S, Lones M, Villaluna D, Weiner M. PMID: 21079154.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    438. Preparing for an aging population and improving chronic disease management. AMIA Annu Symp Proc. 2010 Nov 13; 2010:162-6. Dexter PR, Miller DK, Clark DO, Weiner M, Harris LE, Livin L, Myers I, Shaw D, Blue LA, Kunzer J, Overhage JM. PMID: 21346961.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    439. Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance Imaging. AMIA Annu Symp Proc. 2010 Nov 13; 2010:542-6. Nho K, Shen L, Kim S, Risacher SL, West JD, Foroud T, Jack CR, Weiner MW, Saykin AJ. PMID: 21347037.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    440. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 03; 304(17):1903-11. PMID: 21045096.
      View in: PubMed   Mentions: 181     Fields:    Translation:Humans
    441. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol. 2010 Nov; 67(11):1370-8. Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, Jack CR, Weiner M, DeCarli C. PMID: 21060014.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCellsCTClinical Trials
    442. Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects. Neurology. 2010 Nov 30; 75(22):1976-81. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Jack CR, Aisen PS, Petersen RC, Weiner MW. PMID: 20980669.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    443. Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosis. J Neurol. 2011 Apr; 258(4):603-12. Mueller SG, Ebel A, Barakos J, Scanlon C, Cheong I, Finlay D, Garcia P, Weiner MW, Laxer KD. PMID: 20976465.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    444. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain. 2010 Nov; 133(11):3336-48. Jack CR, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS. PMID: 20935035.
      View in: PubMed   Mentions: 178     Fields:    Translation:Humans
    445. Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One. 2010 Sep 23; 5(9):e12853. Desikan RS, Sabuncu MR, Schmansky NJ, Reuter M, Cabral HJ, Hess CP, Weiner MW, Biffi A, Anderson CD, Rosand J, Salat DH, Kemper TL, Dale AM, Sperling RA, Fischl B. PMID: 20886094.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    446. Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiol Aging. 2012 May; 33(5):845-55. Schuff N, Tosun D, Insel PS, Chiang GC, Truran D, Aisen PS, Jack CR, Weiner MW. PMID: 20855131.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    447. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp. 2010 Sep; 31(9):1339-47. Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW. PMID: 20839293.
      View in: PubMed   Mentions: 109     Fields:    Translation:Humans
    448. Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. Neurobiol Aging. 2010 Aug; 31(8):1386-400. Chou YY, Leporé N, Saharan P, Madsen SK, Hua X, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM. PMID: 20620663.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    449. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging. 2010 Aug; 31(8):1401-18. Risacher SL, Shen L, West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR, Weiner MW, Saykin AJ. PMID: 20620664.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    450. Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiol Aging. 2010 Aug; 31(8):1463-80. Hua X, Hibar DP, Lee S, Toga AW, Jack CR, Weiner MW, Thompson PM. PMID: 20620666.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    451. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. J Neurosci Methods. 2010 Oct 15; 192(2):277-85. Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. PMID: 20678521.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    452. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology. 2010 Jul 13; 75(2):143-51. Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Trojanowski JQ, Shaw LM, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR. PMID: 20625167.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    453. Insomnia severity is associated with a decreased volume of the CA3/dentate gyrus hippocampal subfield. Biol Psychiatry. 2010 Sep 01; 68(5):494-6. Neylan TC, Mueller SG, Wang Z, Metzler TJ, Lenoci M, Truran D, Marmar CR, Weiner MW, Schuff N. PMID: 20598672.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    454. Nearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRI. Neuroimage. 2010 Dec; 53(4):1208-24. Yushkevich PA, Wang H, Pluta J, Das SR, Craige C, Avants BB, Weiner MW, Mueller S. PMID: 20600984.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    455. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010 Jul 20; 75(3):230-8. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Petersen RC, Shaw LM, Trojanowski JQ, Jack CR, Weiner MW, Jagust WJ. PMID: 20592257.
      View in: PubMed   Mentions: 214     Fields:    Translation:Humans
    456. VENTRICULAR MAPS IN 804 SUBJECTS CORRELATE WITH COGNITIVE DECLINE, CSF PATHOLOGY, AND IMMINENT ALZHEIMER'S DISEASE. Proc IEEE Int Symp Biomed Imaging. 2010 Apr; 2010:241-244. PMID: 28316758.
      View in: PubMed   Mentions:
    457. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging. 2010 Aug; 31(8):1284-303. Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, Mathis CA, Weiner MW, Thompson PM. PMID: 20538372.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    458. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging. 2010 Aug; 31(8):1355-63. Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, Brandon M, Guffanti G, Reglodi D, Saykin A, Weiner M, Macciardi F, Schork N, Wallace DC, Potkin SG. PMID: 20538375.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    459. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects. Neurobiol Aging. 2010 Aug; 31(8):1312-25. Madsen SK, Ho AJ, Hua X, Saharan PS, Toga AW, Jack CR, Weiner MW, Thompson PM. PMID: 20538376.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    460. Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging. 2010 Aug; 31(8):1429-42. Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR, Weiner MW, Thompson PM. PMID: 20541286.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    461. Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiol Aging. 2010 Aug; 31(8):1419-28. Nettiksimmons J, Harvey D, Brewer J, Carmichael O, DeCarli C, Jack CR, Petersen R, Shaw LM, Trojanowski JQ, Weiner MW, Beckett L. PMID: 20542598.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    462. Automated MRI measures predict progression to Alzheimer's disease. Neurobiol Aging. 2010 Aug; 31(8):1364-74. Desikan RS, Cabral HJ, Settecase F, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Salat DH, Fischl B. PMID: 20570399.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    463. Alzheimer's Disease Neuroimaging Initiative special issue. Neurobiol Aging. 2010 Aug; 31(8):1259-62. Frisoni GB, Weiner MW. PMID: 20570400.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    464. Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Neurobiol Aging. 2010 Aug; 31(8):1340-54. Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW. PMID: 20570401.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    465. Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging. 2010 Aug; 31(8):1326-39. Ho AJ, Raji CA, Becker JT, Lopez OL, Kuller LH, Hua X, Lee S, Hibar D, Dinov ID, Stein JL, Jack CR, Weiner MW, Toga AW, Thompson PM. PMID: 20570405.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    466. Improved pseudo-continuous arterial spin labeling for mapping brain perfusion. J Magn Reson Imaging. 2010 Jun; 31(6):1419-27. Nezamzadeh M, Matson GB, Young K, Weiner MW, Schuff N. PMID: 20512895.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    467. Network-level analysis of cortical thickness of the epileptic brain. Neuroimage. 2010 Oct 01; 52(4):1302-13. Raj A, Mueller SG, Young K, Laxer KD, Weiner M. PMID: 20553893.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    468. Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure in US veterans. Neurotoxicology. 2010 Sep; 31(5):493-501. Chao LL, Rothlind JC, Cardenas VA, Meyerhoff DJ, Weiner MW. PMID: 20580739.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    469. Patterns of altered cortical perfusion and diminished subcortical integrity in posttraumatic stress disorder: an MRI study. Neuroimage. 2011 Jan; 54 Suppl 1:S62-8. Schuff N, Zhang Y, Zhan W, Lenoci M, Ching C, Boreta L, Mueller SG, Wang Z, Marmar CR, Weiner MW, Neylan TC. PMID: 20483375.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    470. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010 May 12; 303(18):1823-31. Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD. PMID: 20460621.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    471. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010 May; 6(3):239-46. Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW. PMID: 20451872.
      View in: PubMed   Mentions: 154     Fields:    Translation:Humans
    472. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement. 2010 May; 6(3):265-73. Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Nho K, Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR, Weiner MW. PMID: 20451875.
      View in: PubMed   Mentions: 167     Fields:    Translation:Humans
    473. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 2010 May; 6(3):230-8. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR, Jagust W, Toga AW, Lee VM, Shaw LM. PMID: 20451871.
      View in: PubMed   Mentions: 132     Fields:    Translation:Humans
    474. Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement. 2010 May; 6(3):212-20. Jack CR, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW. PMID: 20451869.
      View in: PubMed   Mentions: 138     Fields:    Translation:Humans
    475. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May; 6(3):202-11.e7. Weiner MW, Aisen PS, Jack CR, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M. PMID: 20451868.
      View in: PubMed   Mentions: 167     Fields:    Translation:Humans
    476. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain. 2010 May; 133(Pt 5):1352-67. Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, Kramer JH, Weiner M, Miller BL, Seeley WW. PMID: 20410145.
      View in: PubMed   Mentions: 315     Fields:    Translation:Humans
    477. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A. 2010 May 04; 107(18):8404-9. Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM. PMID: 20404173.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    478. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging. Neuroimage. 2010 Aug 01; 52(1):186-97. Tosun D, Mojabi P, Weiner MW, Schuff N. PMID: 20406691.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    479. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke. 2010 Jun; 41(6):1213-21. Román GC, Salloway S, Black SE, Royall DR, Decarli C, Weiner MW, Moline M, Kumar D, Schindler R, Posner H. PMID: 20395618.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    480. Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults. J Int Neuropsychol Soc. 2010 Jul; 16(4):640-50. Pa J, Possin KL, Wilson SM, Quitania LC, Kramer JH, Boxer AL, Weiner MW, Johnson JK. PMID: 20374676.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    481. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. Hum Brain Mapp. 2010 Apr; 31(4):499-514. Ho AJ, Hua X, Lee S, Leow AD, Yanovsky I, Gutman B, Dinov ID, Leporé N, Stein JL, Toga AW, Jack CR, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM. PMID: 19780044.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    482. The impact of brain size on pilot performance varies with aviation training and years of education. J Int Neuropsychol Soc. 2010 May; 16(3):412-23. Adamson MM, Samarina V, Xiangyan X, Huynh V, Kennedy Q, Weiner M, Yesavage J, Taylor JL. PMID: 20193103.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    483. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Neuroimage. 2010 Jun; 51(2):654-64. Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM. PMID: 20202480.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    484. Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage. 2010 Jun; 51(2):542-54. Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang HM, Eskin E, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin SG, Jack CR, Weiner MW, Thompson PM. PMID: 20197096.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    485. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol. 2010 Mar; 67(3):308-16. Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner M, Petersen RC, Jack CR. PMID: 20373342.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    486. Concordance and discordance between brain perfusion and atrophy in frontotemporal dementia. Brain Imaging Behav. 2010 Mar; 4(1):46-54. Shimizu S, Zhang Y, Laxamana J, Miller BL, Kramer JH, Weiner MW, Schuff N. PMID: 20503113.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    487. Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch Gen Psychiatry. 2010 Mar; 67(3):296-303. Wang Z, Neylan TC, Mueller SG, Lenoci M, Truran D, Marmar CR, Weiner MW, Schuff N. PMID: 20194830.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells